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I N T R O D U C T I O N
The object of this thesis is to describe the modern manage­
ment of the problem of Rhesus isoimmunization. An historical 
review and a description of the material used from a County 
Obstetric Service is given.
The management is considered under three main headings, 
namely:- assessment of severity based on liquor amnii examination; 
treatment of the severely affected foetus by intra-uterine trans­
fusion and, the recent and considerable advance in the prevention of 
iso immuni zat ion *
In the section on liquor amnii examination a cord blood factor 
as an indicator of the degree of severity of the Haemolytic Disease 
at birth is suggested by the author and correlated with liquor amnii 
prediction*
CHAPTER 1
H I S T O R I C A L  R E V I E W
2.
H I S T O R I C A L  R E V I E W
For many years clinicians were puzzled by the condition known 
as erythroblastosis foetalis, now known as Haemolytic Disease of 
the Newborn* There was also lack of knowledge about haemolytic 
reactions following the transfusion of ABO compatible blood to 
certain patients, particularly marked if these same patients were 
further transfused with ABO compatible blood* The unity of 
hydrops foetalis, icterus gravis and congenital haemolytic anaemia 
was established (Diamond, Blackfan and Baty, 1932) but there was no 
obvious explanation why some marriages, with no apparent disease or 
ABO blood group abnormality in either party should result in a 
succession of diseased or stillborn infants showing signs of one of 
the three aforementioned conditions. In 1939 Levine and Stetson 
described an atypical immune agglutinin in the serum of a woman 
after delivery of a stillborn infant showing hydrops foetalis and 
this was the first in a series of rapid developments which led up to 
the present concept of the Rhesus blood group and its clinical 
effects*
In 194c Landsteiner and Wiener reported the findings of a hitherto 
unrecognised antigen by testing human red cells against an anti Rhesus 
serum prepared by injecting blood from Rhesus monkeys into rabbits 
or guinea pigs. This they termed the Rhesus antigen and noted it 
occurred in the erythrocytes of of Europeans.
Later in the same year Wiener and Peters (1940) showed the 
presence of a Rhesus antibody in the blood of Rhesus negative 
patients who had suffered haemolytic reactions following transfusion 
with Rhesus positive blood. Levine, Burnham, Katzin and Vogel
(1941) proved that the formation of Rhesus antibody by a Rhesus negative 
woman frequently resulted in stillbirth or one of the syndromes grouped 
together under the term ’’erythroblastosis foetalis". They suggested 
that the formation of antibody was the maternal response to immunization 
by the Rhesus antigen derived from the foetus which had inherited it 
from its Rhesus positive father.
When all the variations of the Rhesus blood system became known it 
was realised that individuals could have one or two Rh. (D) genes in
their blood. The presence of one Rh. (D) gene made an individual Rhesus
positive and, in that circumstance, there was a 90^ chance of this anti­
gen being passed on by such a father to his offspring, producing a risk 
of Haemolytic Disease in the child. Such an individual is said to be 
heterozygous Rh. (D) positive. Where an individual has two Rh. (D) 
genes in his genetic make-up and fathers a child, he must pass on one 
Rh. (D) gene to his child with the risk, therefore, of producing
Haemolytic Disease in each child. Such an individual is said to be
homozygous Rh. (D) positive. The details of these and the other 
classification of the Rhesus group are well described by Race (1948).
It became evident from this early work that routine testing for 
the Rhesus factor both in transfusion matchings and antenatal screening 
was essential. In the early years of testing sera for the presence 
of anti Rh. (D) agglutinins it was soon recognised that anti Rh. (D) 
antibodies could not be demonstrated in the sera of many mothers of 
babies clinically proven to have erythroblastosis foetalis. Up to 
1944 anti Rh. (D) antibodies were demonstrated by incubating a range 
of cells suspended in saline or citrate with the unknown serum for 
two hours at 37^C. (Levine, 1943a).
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The explanation of these anomalies came simultaneously and 
independently from Race (1944) in England and Wiener (1944) in 
America* They showed that the anti Rh# (D) antibodies occurred 
in two forms - a blocking and an agglutinating type and that the 
former was capable of inhibiting the agglutination of Rh# positive 
cells by the latter. Race (1944) gave the name incomplete to this 
type of antibody. Later in 1943 Coombs, Mourant and Race showed 
that cells sensitized with an incomplete or blocking antibody and 
washed free of other non-specific proteins would show agglutinations 
after the addition of an anti-human-globulin serum. This anti- 
human-globulin serum was prepared by the immunization of rabbits 
with whole human serum or globulin or pseudoglobulin fractions.
They were all equally suitable as the test reagent after they had 
been absorbed with a mixture of washed cells of Groups A, B and 
0.
With the knowledge that two types of antibody - a saline 
antibody and a blocking or incomplete antibody - existed and, 
that the latter could be missed without adequate testing, it became 
obvious that both tests had to be carried out routinely in antenatal 
blood tests and transfusion matchings.
With the elucidation of the cause of Haemolytic Disease came
the early attempts at treatment. Initially when a pregnancy was
diagnosed and the foetus suspected of having Haemolytic Disease 
three lines of action were considered:-
(1) Induction of abortion
(2) Induction of premature labour
(3) Allowing the pregnancy to go to term
3.
In (2) and (3), preparations were made to transfuse the baby 
on delivery if necessary.
INDUCTION OF ABORTION
This was rarely considered and then only where there was a 
previous stillbirth due to isoimmunization and the father was known 
to be homozygous. Termination of pregnancy in these cases was 
carried out in the first trimester.
INDUCTION OF PREMATURE LABOUR
This was suggested by Diamond (194?). It was appreciated that 
this imposed the additional risk of prematurity on these infants 
but did improve the infants chance of recovery from Haemolytic Disease, 
Diamond (194?) suggested that induction was best carried out at 37-3^ 
weelis but Mollison (1948) mentions 33 weeks in the case of a woman 
who has had one or more severely affected infants. Action was
only taken when it was virtually certain, or extremely probable, that 
the foetus was severely affected. Planned induction of labour was 
based on the presence of isoimmunization in the mothers with evidence 
of increase in sensitization in the pregnancy, indicated by a rise in 
antibody titre, or a previously affected child and homozygosity of the 
husband.
THE TREATMENT OF THE AFFECTED INFANT
The treatment of the affected infant was either a simple trans­
fusion or the then new exchange technique of Diamond (194?). A 
decision to transfuse or not was taken largely on clinical examination 
plus examination of the cord blood. The most important findings 
were regarded as the rapid onset of jaundice and a haemoglobin of
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12 gm»% or less* VHien the condition of the baby was judged as 
severe by these standards an exchange transfusion was performed 
soon after delivery. In milder cases a simple transfusion, 
either via the umbilical vein or a scalp vein, was given. Over 
the years these techniques have been mastered and improved.
At this time most research was applied to the amelioration 
of the effects of Haemolytic Disease on the foetus. Of the early 
attempts to improve foetal results one of the best known is that of 
Carter (194?) who introduced the use of Rh. Hapten. A Hapten is 
a substance which, when combined with a suitable carrier such as 
protein, can stimulate antibody production in a host and can also 
react specifically with that antibody, but which without a carrier 
cannot by itself initiate antibody production. Carter's rationale 
in the use of the Rhesus Hapten was to neutralise the existing anti­
body in a patient without stimulating the production of more antibody. 
The Hapten was given initially by intramuscular injection in large 
amounts but in 1938 Carter and Lewis published a paper giving success­
ful results in 17 sensitized patients using the Hapten orally. One 
of the essentials of Carter's treatment was that the Hapten had to 
be given between pregnancies and during pregnancy.
As Rh. Hapten was prepared from freely available time expired 
red cells it is surprising that no other worker confirmed the value 
of this substance.
A further attempt to prevent damage to the foetus of the sensitizei 
mother was the use of corticosteroids. The rationale in their use 
was the hope that the production of the maternal antibody might be 
suppressed and that severity and rapidity of destruction of the foetal 
cells might be lessened. Opinion on the use of corticosteroids was
7.
divided. Hunter (1934) claimed that they were of value but 
De Costa, Gerbie and Potter (1934) disagreed as did Wiener (1934).
The use of corticosteroids was shortlived as their value, if any, 
was minimal and their use carried some risk to the mother.
A modern attempt to protect the foetus by reducing the level 
of circulating maternal antibody and thereby reducing the potential 
effect on the foetus is by the use of plasmapheresis in pregnancy.
This process involves the removal of large quantities of blood by 
venesection, removing the plasma and returning the red cells to 
the patient. This has been shown to reduce the antibody level but 
the effect is transient and the titre rises to its original level in 
a few weeks (Powell, I968; Clarke, Elson, Bradley, Donohoe, Lehane 
and Hughes Jones, 1970)*
These measures will be discussed more fully when the problem 
of prevention of isoimmunization is discussed in detail.
While these problems were being investigated other aspects of 
Haemolytic Disease were also receiving attention. It had been 
recognised by Pickles (1949) that the liquor amnii in a case with a 
badly affected foetus was golden in colour. Bevis in 1933 examined 
the contents of liquor amnii and in 1938 the relationship of liquor 
bilirubin and the later development of kernicterus. It was realised 
from his work that amniocentesis was a relatively simple procedure 
and several workers began to study liquor carefully with particular 
reference to the "bilirubin pigment" content.
Following the lead of Bevis many workers became interested in 
the bilirubin pigment content of liquor amnii as a means of prediction
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in Haemolytic Disease. From the publication of a paper by Walker 
(1937) to the present time a great deal of experience has been 
accumulated on technique and dangers of amniocentesis, methods of 
examination of the liquor and correlation between liquor prediction 
and outcome of the pregnancy. Of the many contributors - Mackay 
(1961); Alvey (1964); Walker, Fairweather and Jones (1964);
Stewart, Taylor and Beck (I967) and Freda (I963) to name only a few, 
the most outstanding contribution has come from Liley, (I96I). He 
rationalised the whole problem by producing from his own work a 
graph which related liquor findings to severity of affection of the 
foetus at different stages of gestation.
Using spectrophotometry to examine the liquor amnii in a large 
series of sensitized patients, Liley was able by correlating the 
liquor predic tion to the outcome of the pregnancy to divide his liquor 
prediction into three zones - Upper, middle and lower. The 
lower zone contained results which indicated that the baby would be 
mildly affected or unaffected. The middle zone contained results 
which indicated that the baby would be moderately affected, probably 
needing an exchange transfusion, and the upper zone contained results 
which indicated that the baby would be badly affected. These three 
zones Liley superimposed on a semilogarithmic graph using the optical 
density of liquor on a logarithmic scale as the ordinate and the 
maturity in weeks was plotted as a simple scale on the abscissa.
Most other workers since then have used Liley*s graph either in 
its original form or with some modification, as a basis for their own 
series. From the early nineteen sixties, examination of liquor 
amnii has played an important part in the antenatal prediction of 
severity of Haemolytic Disease and the stage has now been reached
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that, with the use of liquor predictions, the disaster of very early 
induction of a Rhesus negative baby should no longer occur.
In 1961 Liley made a major contribution to the Rhesus problem 
by his work on liquor amnii but in I963 he made a further important 
contribution in the field of active treatment of the foetus endangered 
by Haemolytic Disease^ by introducing intra-uterine transfusion.
This meant that once a foetus was judged to be severely affected by 
Haemolytic Disease active treatment could be instituted. Liley, 
having found how relatively simple it was to enter the peritoneal cavi 
of a hydropic foetus during amniocentesis,remembered the fact that 
blood could, in the young, be absorbed into the circulation from the 
peritoneal cavity and put this into therapeutic use. Many other 
workers have followed his example (Karnichi, 1966; Friesen, Bowman, 
Barnes, Grev/ar, Mclnnis, Bowman (1967); Fairweather, Tacchi, Coxon, 
Hughes, Murray, Walker, I967) and the use of intra-uterine transfusion 
is now an accepted practice. The procedure does not salvage the 
baby in all cases and is not without risk to mother or foetus but it 
gives some hope to the patient with a history of repeated stillbirths 
and its introduction was a landmark in the history of Haemolytic 
Disease.
While these clinical advances were being established, work on 
the problem of prevention of formation of antibodies was being 
tackled with renewed vigour. Levine (1943) suggested that ABO 
incompatibility between mother and foetus afforded some protection 
against Rhesus immunization. Race and Sanger (1930) suggested 
that isoimmunization v/as probably due to the passage of foetal cells 
into the maternal circulation and that the ABO incompatible cells of 
the foetus were destroyed in the maternal blood stream by naturally 
occurring anti A and anti B agglutinins before sensitization by the 
foetal cells could occur.
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Experimental work by Stern, Davidsohn and Masaitis (1936) using 
Rhesus negative male volunteers supported the idea of protection by 
ABO incompatibility. They injected Rhesus positive blood into 
Rhesus negative male volunteers and noted that much higher titres of 
anti Rh. (D) were obtained when compatible ABO blood was injected than 
when incompatible blood was used.
Clarke, Finn, McConnell and Sheppard (1938) carried out family 
studies to test Levine's theory of ABO protective mechanism and found 
that in 14 of 23 families where the parents were ABO incompatible the 
sensitizing foetus was ABO compatible with the mother.
Almost simultaneously work was going on to establish the fact 
and importance of transplacental haemorrhage from baby to mother. In 
1937 Kleihauer, Hildegard and Betke demonstrated the presence of small 
numbers of foetal erythrocytes in maternal circulation using his own 
staining technique. Zipursky, Hull and White (1939) and later Finn, 
Clarke, Donohoe, McConnell, Sheppard and Lehane (I96I), using the 
Kleihauer technique, showed that an appreciable transplacental haemoril 
occurs during the third stage of labour.
Kreiger (I966) showed conclusively that transplacental haemorrhage 
may also occur during pregnancy.
Having established that maternal sensitization was probably causée 
by small "transfusions" from a Rhesus positive foetus, transplacental 
haemorrhage was then investigated in detail by Chown (1934); Kleihaue] 
et al (1937); Finn, Clarke, Donohoe, McConnell, Sheppard, Lehane (I96* 
Cohen and Zuelzer (1964); Cohen and Zuelzer (I967) and Woodrow, Clark< 
Donohoe, Finn, McConnell, Sheppard, Lehane, Russell, Kulke and Durkin
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(1963) with particular reference to:-
(1) Incidence of transplacental haemorrhage
(2) Correlation between circulating foetal cells and the 
production of Rhesus antibodies
(3) Time of foeto-maternal haemorrhage
(4) Association with obstetric manoeuvres during pregnancy and 
delivery
Simultaneously with these investigations experimental work was 
going on in Liverpool to investigate the effect of injecting Rhesus 
negative male volunteers with Rhesus positive blood and treating half 
of them with plasma containing anti Rh. (D) (Finn et al, 196I). The 
results of this experiment suggested that anti Rh. (D) played an 
effective part in rapidly removing Rhesus positive cells from the 
circulation thus preventing the formation of antibodies. Clarke, 
Donohoe, McConnell, Woodrow, Finn, Krevans, Kullce, Lehane and Sheppard 
(1963) showed also experimentally in Rhesus negative male volunteers 
that the injection of plasma containing the saline anti Rh. (D) antibody 
following the injection of Rhesus positive blood enhanced antibody 
formation.
During this experimental work, plasma containing anti Rh. (D) was 
used and all workers were aware of the danger of transmitting homologous 
serum jaundice by the use of plasma. In 1964 Freda, Gorman and Pollack 
produced a gamma globulin fraction which does not carry the risk of 
transmitting homologous serum jaundice, prepared from the plasma of 
donors each of whom had a high titre of anti Rh. (D) by the indirect 
antiglobulin method. This fraction was prepared by a modification of 
the Cohn fractionation technique and sterilized. This was used 
experimentally on Rhesus negative male volunteers with similar results 
to that obtained by the Liverpool workers.
12.
These early experiments were all carried out on male volunteers. 
There was no reason to suppose that the Rhesus negative female would 
react differently to the male when injected with Rhesus positive 
blood. Woodrow et al (1963) injected Rhesus positive foetal cells 
into 10 Rhesus negative nulliparous postmenopausal women and gave anti 
Rh. (D) gamma globulin. They showed that the Rhesus positive foetal 
cells could be cleared from the circulation of these women as 
effectively as the adult Rhesus positive cells could be cleared from 
the adult male Rhesus negative volunteers.
The first clinical trials of anti Rh. (D) gamma globulin were 
carried out in I966 in several centres in England and Baltimore.
The gamma globulin was given in 5 ml. amounts only to patients who 
delivered a Rhesus positive ABO compatible baby and was given in the 
first 36 hours after delivery (A Combined Study, I966).
In this combined study patients were given anti Rh. (D) gamma 
globulin and 78 controls were not. Of the 78 patients treated none 
were found to be immunized at an interval of six months or later after 
delivery but 19 of the 78 controls were immunized at a similar interval 
of time. In a series reported by Clarke (I967) with results from 
various centres with a total of 1,227 women in the study, 75 out of 
359 controls were found to have antibodies six months or later after 
delivery and only one out of 628 treated women developed antibodies in 
the same period of time.
The amount of gamma globulin given was 3 ml. but the actual amount 
of anti Rh. (D) gamma globulin was not known. With improved techniques 
of measurement (Hughes Jones, 1967) the dose can now be measured in 
microgrammes. The average dose used in Rhesus negative women who
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deliver Rhesus positive ABO compatible children is now 200 micro­
grammes. This has been available for such women in a first 
pregnancy since March, I968. It may be that a smaller dose will 
suffice except in the case of a massive transplacental bleed.
Further trials, as yet unpublished, are now taking place to try and 
establish the minimal effective amount of anti Rh. (D) gamma globulin 
required.
Scarcity of raw material and hence gamma globulin has made a 
choice of priorities essential. The anti Rh. (D) gamma globulin 
was given initially only to Rhesus negative primigravid women who 
delivered a Rhesus positive ABO compatible baby and who did not have 
anti Rh. (D) in their serum.
At the moment, most raw plasma containing anti Rh. (D) comes from 
women who have been sensitized by pregnancy or by an incompatible blood 
transfusion but this will not be adequate. To augment the supply of 
raw material plasma is being obtained from postmenopausal isoimmunized 
women who have been given booster doses of Rhesus positive cells and 
from Rhesus negative male volunteers who have been immunized by the 
injection of Rhesus positive blood. This as yet has only been done 
in certain parts of the country on a small scale but the programme will 
have to be extended to ensure adequate supplies of anti Rh. (D) gamma 
globulin for the future*
The process of plasmapheresis (see Page I56) has been developed 
with these donors. Fairly large amounts of plasma can be obtained 
at one time from each donor on a planned programme and the donors are 
able to undergo plasmapheresis more often than giving a simple donation 
of whole blood.
Since the efficacy of anti Rh. (D) immunoglobulin has been 
established large amounts of anti Rh. (D) containing plasma are 
now required* This is most easily obtained by the use of 
plasmapheresis of suitable donors.
14.
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MATERIAL AND ORGANISATION
The material for this thesis was acquired during the eleven 
year period 1958-1968 in the County of Lanark. The work was 
carried out at Bellshill Maternity Hospital which, until I962 
contained 112 beds and 24 cots for sick and premature babies.
In 1962 a new hospital was opened and this contained 1^2 beds and 
96 cots for sick and premature babies. In conjunction with Bellshill 
Maternity Hospital work was carried out at The William Smellie 
Memorial Hospital, Lanark « a 90 bedded hospital serving the southern 
part of the county. These two specialist hospitals between them 
dealt with 9,000 deliveries which included the abnormal cases from 
the remaining 9,000 patients delivered in the county^ per annum.
During the development of the specialised care of the Rhesus 
patients in Lanarkshire I have been allowed to play a unique part.
From 1996 to 1964 I was employed as a Neonatal Paediatrician at 
Bellshill and the other maternity hospitals in Lanarkshire with the 
additional responsibility of two antenatal clinics. I rapidly 
developed an interest in the Rhesus problem and I was encouraged by 
the Senior Obstetricians to start the Rhesus clinic. As a result 
I had both antenatal and postnatal care of the babies which meant I 
could maintain continuity with each mother during the critical neo­
natal period when exchange transfusion might be necessary. When 
the regular meetings at The Regional Transfusion Centre started I 
was responsible for the collection of the clinical data and attended 
these meetings with my senior colleagues.
In 1964 I moved to a post in The Regional Transfusion Centre 
where I developed an interest in the laboratory investigation of 
these patients. I have been fortunate, however, in that I have
21.
retained an active part in the clinical care of the Rhesus patients 
including carrying out amniocentesis and intra-uterine transfusion.
Since anti D gamma globulin was first used in I967 in this area 
in prevention of isoimmunization I have taken a co-ordinating role 
in the organisation and record keeping of this work. I have also been 
the Medical Officer in charge of plasmapheresis for the collection of 
material for processing for anti Rh. (D) gamma globulin.
The policy of management of the Rhesus isoimmunized pregnant 
women in the late nineteen fifties in Lanarkshire was that of induction 
at 38-39 weeks with an occasional early Caesarean Section about 36 weeks 
if there was a history of previous stillbirth and a homozygous husband. 
Specimens of blood were taken from antenatal patients attending one of 
the sixteen clinics throughout the county at the first visit and then at 
28 weeks. If antibodies were found at 28 weeks specimens of blood 
were examined thereafter at fortnightly intervals. If antibodies were 
discovered at the first visit, specimens of blood were examined at 
monthly intervals until 28 weeks and then at fortnightly intervals 
thereafter. When possible blood was obtained from the patients* 
husbands for phenotyping.
The decision to induce or otherwise was made by the individual 
obstetrician in charge of each antenatal clinic with the exception of 
the difficult case with a poor past history when reference was made 
to one of the senior consultants. The decision when to terminate a 
pregnancy was on antibody titre alone. Superficially this seemed 
to be a reasonable arrangement but because of the widespread area 
covered by the numerous antenatal clinics and the fact that specimens 
of blood were not examined in the hospital but in a laboratory some 
miles away there was occasional unavoidable delay in a clinical 
decision being made on a particular patient with unfortunate results.
22.
In i960 it was decided to establish a special antenatal clinic 
for the Rhesus sensitized patient both at Bellshill Maternity 
Hospital and The William Smellie Memorial Hospital at Lanark. This 
enabled patients from both halves of the county to be centralised 
at one of two places. A policy of induction at 38 weeks generally 
and earlier induction of specific patients was decided upon. This 
decision was based on antibody titres, previous history and geno­
type of husband.
An immediate effect of the establishment of these clinics was 
that the patients felt that their special problems were being 
actively treated,particularly as a close liaison was maintained with 
the paediatric unit. This was particularly true of patients who 
had previously had a baby transfused. All patients were referred 
to the special clinic as soon as antibodies were detected in their 
blood at routine antenatal clinics. With standardisation of ante­
natal care and induction, the outcome of pregnancy in the sensitized 
woman began to improve. This is illustrated in Table 11.
Still, however, there remained the problem of a woman with a 
heterozygous husband, a previously affected baby and a rapidly 
rising titre of antibody. After delivery of one of these women 
at 37 weeks of a Rhesus negative baby it was decided to look at the 
problem more closely. This was helped enormously by the fact 
that a short time previously The Regional Blood Transfusion Centre 
had moved to Law Hospital situated roughly halfway between Bellshill 
Hospital and The William Smellie Hospital and all antenatal and 
cord bloods were examined there. At the invitation of The Regional 
Director a meeting at regular intervals was established at The 
Transfusion Centre to discuss the sensitised cases. At each of 
these meetings^ held monthly^ all the clinical and laboratory facts
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and figures were made available. The meetings, now held at three­
weekly intervals, were attended by The Regional Director of The 
Transfusion Service and his deputy, a Consultant Obstetrician and a 
Paediatrician. As the number of cases increased with time, a 
wealth of experience was acquired from these meetings. A close 
liaison formed between the clinicians and the laboratory staff of 
The Regional Transfusion Service. This liaison became even closer 
with the introduction of amniocentesis since the liquors were examined 
at The Regional Transfusion Centre and another parameter was added to 
the consideration of each case.
Figure 1 illustrates the organisation. Sixteen routine ante­
natal clinics referred their cases to the special Rhesus clinic.
Cases were discussed at The Regional Transfusion Centre and eventually 
admitted to hospital with a firm decision as to their management.
In summary, the evolution of the present day management of the 
Rhesus sensitized patient in Lanarkshire has been as follows:-
(1) The establishment of special Rhesus antenatal clinics within the 
Specialist Maternity Hospitals of the County.
(2) In association with the clinics, a regular three-weekly meeting 
■was established to discuss the cases and make a decision on time 
and method of delivery of the patients.
(3) The introduction of the more sophisticated techniques of ante­
natal prediction and management in addition to (l) and (2) above.
FIGURE 1
2%,
Routine 
A.N. Clinic
Routine Routine Routine Routine
A.N. Clinic A.N. Clinic A.N. Clinic A.N. Clinic
SPECIAL RHESUS CLINIC
R.T.C. MEETING
HOSPITAL
KEY A.N, Antenatal R.T.C. Regional Transfusion Centre
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The total number of sensitised cases dealt with in the period 
1958-1968 was 917 » The total number of hospital deliveries in this 
period was 55*000 and the total number of deliveries in the County 
of Lanarkshire was 110,000. The percentage of sensitised women in 
the hospital patients was, therefore, small (1.7)• As the Lanark­
shire Maternity Hospitals cared for most of the cases requiring 
specialist care in the County and, in particular, after I960 when 
the Rhesus clinic was established, it can be safely said that all 
the sensitised cases in the County were confined in one or other of 
the specialist hospitals and thus the percentage of sensitised cases 
in the county was 0.8.
For convenience these cases have been divided into three broad 
groups :-
(1) Pre Rhesus clinic group when the care of sensitised patient
was incorporated into general antenatal care and the only policy 
was one of induction of labour at 38 weeks.
(2) Rhesus clinic group when these cases were brought together and 
looked after by one person and a formula for management evolved.
(3) Rhesus clinic and amniocentesis group when the policies of manage­
ment begun by the clinic continued in association with the more 
advanced forms of investigation.
The following tables are included to show in more detail the 
type of material and the overall results.
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A M N I O C E N T E S I S
The association of yellow amniotic fluid and hydrops foetalis 
has been appreciated since 1949 (Pickles) but only since the 
initiation of the investigation of liquor amnii by spectrophotometry 
and biochemistry by Bevis (1933* 1936) has it been realised how much 
valuable guidance in antenatal prediction could be obtained from the 
study of it. Bevis was originally concerned with the contents of 
liquor amnii with particular reference to the breakdown of haemo­
globin and he tried to relate the concentration of non-haematin iron 
to the severity of Haemolytic Disease of the Newborn. He measured 
various substances present in liquor and his general conclusion was 
that an increase in the non-bilirubin icteric index was followed by 
kernicterus.
Since Bevis*s work many others have investigated the constituents 
of liquor amnii in relation to Erythroblastosis Foetalis. Its 
potential as a valuable guide to the severity of the disease and to 
antenatal management is now realised. As might be expected,the 
method has limitations but to date it is considered to be the best 
single diagnostic aid.
BILIRUBIN CONTENT OF AKNIQTIC FLUID
Two methods of the assessment of the bilirubin content of amniotic 
fluid have been used.
These are:-
33.
A. USING SPECTROPHOTOMETRY 
This is used in two ways:-
(1) By grading according to the shape of the spectral 
absorption curve by visual inspection (Walker, 1937; 
Carey, I96O; Mackay, I96I).
(2) By optical density difference measurements obtained 
from the spectral absorption curves (Liley, I96I; 
Watson, 1962; Robertson, 1964; Knox, Fairv/eather 
and Walker, 1963; Alvey, 1964).
B. CHEMICAL ESTIMATION
This is claimed by some workers to be more accurate 
than spectrophotometry (Beecham, Molthan, Boutv/ell and 
Rohrbeck, I962; Watson, 1962; Mackay and Watson, 1962; 
Bevis, 1933; Stewart and Taylor, 1964; Stewart, Taylor 
and Beck, 1967; Walker, Landon and Oxley, I969), but in 
view of the very small amount of bilirubin being measured 
these techniques require considerable expertise in bio­
chemical methods.
In this series the spectrophotometrie method has been 
used as the examination of choice but in some instances 
both methods have been carried out. It is felt, however, 
that spectrophotometry gives the more accurate result 
(Milne, 1966).
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It is not entirely certain if the substance which 
colours the liquor is bilirubin but it is certainly a 
substance which bears a close resemblance to bilirubin 
on examination by biochemical and spectrophotometrie 
methods and for practical purposes it is assumed to be 
bilirubin. The route by which bilirubin reaches the 
liquor is not yet known nor to what extent its level is 
dependent on other constituents or turnover rate of the 
liquor. This does not prevent an empirical evaluation 
of bilirubin like substance in the liquor being of clinical 
significance.
TECHNIQUE OF AI^IOCENTESIS
Amniocentesis can be done at an out-patient clinic provided 
an aseptic technique is maintained. It causes little discomfort 
to the patient and when the purpose of the test is explained 
patients are most co-operative.
The patient lies comfortably on an examination couch for 
several minutes to allow a mobile foetus to settle and the foetal 
position is then carefully palpated and a decision taken as to the 
point of entry. Liquor can be most easily obtained from the area 
over the foetal limbs, from behind the foetal neck, from below the 
presenting part and occasionally from above the foetus near the 
fundus of the uterus. In practice the optimum point of entry
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is often below and to the left or right of the umbilicus.
The abdominal skin is cleansed with suitable agents e.g.
Hibitane in alcohol and draped with a sterile towel. The site 
of entry is infiltrated down to the peritoneum with 1 percent 
Xylocaine using a 21G x ij’* disposable needle. In many thin 
subjects liquor amnii can often be obtained via this needle and 
only the syringe need be changed to withdraw the required 10 mis. 
of liquor. If liquor is not obtained, particularly if the patient 
is obese, a disposable lumbar puncture needle (Brunswick 220 size 
20 X is inserted, liquor is withdrawn and placed in a sterile
universal container which is immediately protected from light by 
wrapping in black paper or tinfoil.
The abdominal puncture, after removal of the needle, is sealed 
with Collodion and the patient tali en to the canteen for a cup of 
tea. This enables her to be under observation for fifteen to 
twenty minutes and, if all is well, she goes home having been told 
to report immediately any adverse effect.
The specimen is centrifuged almost immediately at 3,000 rev./ 
minute for fifteen minutes. This is most important if blood-stained 
liquor has been obtained in order that the blood may be removed before 
haemolysis of the red cells takes place as this may mask the true 
bilirubin values. Centrifugation removes traces of vernix, epithelial 
cells etc. which may also be present.
The naked eye appearance of the supernatant is noted. Further 
examination is not carried out till the next day but the specimen is
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protected from light and kept at 4-6^0. Protection from 
light is essential since bilirubin is decomposed rapidly on 
exposure to sunlight. Liley (I96I) found that the pigment 
had a half life of ten hours in laboratory daylight and 12-18 
minutes in winter sunshine. Protected from light he found 
no change in liquors examined after keeping in a refrigerator 
for nine months or after storage for thirty days at room 
temperature.
DANGERS OF AMNIOCENTESIS
Amniocentesis is not without danger to mother and child 
(Liley, i960) but the value of the information obtained from 
liquor examination outweighs the risks.
The commonest hazards are as follows:-
(a) DANGER TO THE MOTHER
(1) INFECTION
A few cases of rigor and elevation of temperature which 
rapidly settled have been reported but generally infection 
is not a significant problem (Fairweather and Walker,
1964).
(2) ANTE-PARTUM HAEMORRHAGE
On occasion the placenta cannot be avoided particularly
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where it is of the large type associated with 
Haemolytic Disease of the Newborn and lying anterior­
ly. If the needle puncture is clean there appears 
to be little risk of detachment of the placenta. If 
a vessel is pierced or damaged^blood may leak into the 
liquor and obscure the findings. Cases of abruptio 
placentae with risk to the mother and with fatal results 
to the foetus have been occasionally reported (Robertson, 
1964).
(b) FOETAL DANGERS
(1) INFECTION
Infection to the foetus has rarely been reported 
(Robertson, 1964; Liley, I96O).
(2) DIRECT TRAUMA
In severely affected babies, enlarged by oedema, the 
needle may pierce the child. Unless a vital organ or 
foetal vessel is damaged, however, the foetus appears 
to come to little harm. Foetal exsanguination has been 
reported (Stenchever and Cibils, I968). In this series 
in one patient the foetal heart could not be heard after 
blood-stained liquor had been obtained at amniocentesis 
and the ensuing intra-uterine death must be attributed 
to trauma of some kind. Post-mortem examination was 
inconclusive.
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(3) FOETAL/MATERNAL BLEEDING
Foetal/Maternal bleeding may cause an increase in 
antibody level with additional foetal risk. This 
risk has been noted (Queenan and Adams, 1964; Peddle, 
19683 Zipursky, Pollock, Chown and Israels, I963) but 
reports by Freda (I963) and Fairweather, Murray, Parkin 
and Wallier (1963) indicate that the risk is negligible 
and certainly should not contra-indicate amniocentesis.
In this series one case developed a saline antibody where 
only an antibody detectable by the indirect antiglobulin technique 
had been present before amniocentesis. This is said by Murray 
(1967) to carry a poor prognosis and this patient had a stillbirth. 
Her previous history, however, was poor. Two other patients had 
a rise in titre but this did not affect the outcome in so far as 
each had a live child which survived.
SOURCES OF ERROR IN EXAMINATION OF LIQUOR AMNII
(a) FLUIDS OTHER THAN LIQUOR AMNII
Such fluids may come from several sources but on close 
examination the nature of the fluid can be easily identified.
(1) MATERNAL URINE
This should rarely happen if the patient empties her 
bladder before amniocentesis but should such an accident
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occur the fluid can be identified by smell, lack of 
vernix, lack of squamous cells and lanugo hairs.
(2) FOETAL ABCITXC FLUID
This is intensely pigmented fluid which can be recognised 
with the naked eye. Since this is obtained usually 
before or during intra-uterine transfusion the source can 
be recognised from the position of the needle as seen on 
an x-ray film.
Further error could be made by the aspiration of 
fluid from a meningocoele. This might be diagnosed by 
a good x-ray film and in any case examination of the 
protein constituents of this fluid and of ascitic fluid 
can establish the source with certainty. The protein
constituents can be identified by electrophoretic 
techniques.
(3) MULTIPLE AMNIOTIC SAGS
Plural pregnancy is diagnosed clinically. By the injection
of Evans blue into one sac after amniocentesis the operator 
can make certain that further liquor is from the second sac 
which should be free from dye.
(4) AMNIOTIC CYSTS
These are rare. The fluid is turbid and has a high
content of protein and fat which can be recognised by
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biochemical analysis.
(b) PIGMENTS OTHER THAN BILIRUBIN
(1) SERUM AND HAEMOGLOBIN
Error is particularly likely if the liquor is contaminated 
with serum of an affected baby since this will contain 
high levels of bilirubin. The effect of such contamination 
is less if the baby is unaffected or if the serum is maternal 
for the reason that these contain much less bilirubin.
Where haemoglobin and red cells are contaminants a 
diagnosis of the source of the blood i.e. foetal or 
maternal can be made by alkali dénaturation tests for 
haemoglobin and examination of the cells by grouping.
Direct Anti Globulin test and a search for nucleated 
red cells. Haemoglobin contamination takes 2-3 weeks 
to clear from the liquor. Haemoglobin can be corrected 
for by extending the wavelengths over which spectro- 
photoraetric readings are made.
The type of curve obtained from liquor amnii contaminated 
by haemoglobin can be seen in Graph 1.
(2) MECONIUM
The presence of meconium is rare in the early part of 
the third trimester but in any case the absorption curve 
differs from that of bilirubin. Maximum absorption when
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meconium is present is at 405-411 n* Heavy meconium- 
staining can cause difficulty in interpreting the 
result of liquor examination but it has been found that 
meconium clears from the liquor in a week and reliable 
readings are obtained once more. A graph illustrating 
this is shown on Page 82.
(3) CONGENITAL ABNORMALITIES
For some reason, perhaps related to the swallowing of 
liquor by the foetus, the bilirubin content of liquor 
is raised if congenital abnormality is present. In two 
non-sensitized cases examined, where hydramnios was present 
and liquor was examined out of interest, although no Rhesus 
problem was present, a high bilirubin content was found by 
spectrophotometry. One child had a meningomyelocoele and 
the other an exomphalos with associated duodenal atresia. 
Such an abnormality in a sensitized mother could well upset 
prediction results based on liquor examination*
(c) EFFECT OF MATURITY
(1) DOUBTFUL MENSTRUAL HISTORY
An error, in some cases, may be accounted for by a mistake 
in the patient's assessment of her expected date of con­
finement as the significance of the liquor reading varies 
with maturity*
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(2) MATURITY AT DELIVERY
If a general assessment is made in terms of the infant's 
cord blood findings an apparent error may occur because 
of a planned or spontaneous premature delivery since, in 
premature deliveries, a higher cord blood haemoglobin may 
be found than in infants delivered at full term*
The early attempts to measure bilirubin and other elements in 
liquor amnii were discouraging (Beecham, Molthan, Boutwell and 
Rohrbeck, I96I; Watson, I962) but this was probably in part due to 
the reluctance of clinicians to obtain adequate and frequent specimens 
of liquor amnii as this seemed to be an unjustifiable risk to mother 
and foetus. Recent work and, in particular, that of Liley (I96I)
has shown how useful the study of amniotic fluid is in the prediction 
of severity of Haemolytic Disease of the Newborn. It should be said, 
however, that each laboratory must develop its own methods and its 
own standards* The position has now been reached where no baby need
be lost through inopportune Intervention nor should a mother be allowed 
to deliver a severely affected child without the severity of the disease 
being known to her obstetrician,for it is now possible for the 
obstetrician to have a reasonably reliable assessment of the severity 
of the disease.
METHODS OF LIQUOR EXAMINATION
In 1961 Wild suggested that liquor bilirubin levels may be 
influenced by the protein level as had been demonstrated by Stempfel 
and Zetterstrom in 1955* Both values fall as pregnancy advances
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so allowance must be made for the maturity of the foetus when 
interpreting results by these methods. Walker, Fairweather and 
Jones (1964) had calculated a bilirubin/protein ratio, measuring 
the protein by the Folin and Ciocalteau method and measuring the 
bilirubin spectrophotometrically. The findings of Walker et al
(1964) were at variance with those of Cherry, Kochwa and Rosenfield
(1965) and Morris, Murray and Ruthven (I967) who believed that 
bilirubin/protein ratio was of value in estimating the severity of 
Haemolytic Disease.
In 19691 Walker,Landon and Oxley repeated this work but using 
the Biuret method for protein estimation. They again found that 
the estimation of protein did not give as good a prediction of 
severity of Haemolytic Diseases as did bilirubin estimation alone 
and that there is nothing to be gained by linking bilirubin with 
protein estimations.
In 1967, Stewart, Taylor and Beck described a method by which 
bilirubin in amniotic fluid is estimated by a method in which 
bilirubin is coupled with Diazotized Sulfanilic acid in the presence 
of an aqueous accelerator and the subsequent Azobilirubin read 
photometrically. This is the same method which has been used 
for microplasma bilirubin estimations except that the sample size 
is increased forty times without changing the fluid sample volume.
It is this fortyfold increase in sensitivity that enables the method 
to be used for the very low concentrations of bilirubin found in 
liquor amnii. These authors claim that by the use of this method 
more reliable results are obtained than by the use of spectro­
photometry since the corrections for turbidity and/or haemoglobin
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are uncertain in optical density methods. Such corrections 
are not, of course, necessary in the chemical methods of 
estimating bilirubin in liquor. Stewart et al successfully 
relate their predictions to the three zones of Liley as shown 
in Page ^3 - mild, moderate and severe dependent on the
bilirubin levels.
A further method of prediction by biochemical measurement 
of amniotic fluid bilirubin is suggested by Brazie, Bowes and 
Ibbott (1969). This consists of the extraction of the un­
conjugated bilirubin in liquor by shaking with chloroform and the 
determination of the bilirubin concentration in the chloroform 
layer. They claim that no interference with accuracy occurs in 
samples containing excessive haem pigments, meconium and turbidity 
and that the values obtained show excellent correlation with 
those obtained by the method of Liley for estimating the bilirubin 
by optical density at the 450n peak. These authors claim that 
their method is simple and is more sensitive and less cumbersome 
than standard methods of quantitating bilirubin by the Diazo 
reaction. They claim recoveries of bilirubin added to liquor 
amnii to be between 90-94 percent as do Pennington and Hall (I966) 
and that the coefficient of variation of estimation of bilirubin 
from amniotic fluid with chloroform was less than 1 percent at a 
level of 0.1 ragm./lOO ml.
In their hands Brazie et al (I969) show that this method of 
bilirubin measurement is of value. The writer's experience 
suggests, however, that the extraction has to be repeated several
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times and thus leads to inaccuracy from loss of bilirubin since 
the amount of bilirubin being measured is so small.
By far the most widely used methods of estimating the 
bilirubin content of liquor amnii are those involving spectro­
photometry and the greatest contribution to this aid in prediction 
was made by Liley in I96I. Although Bevis (1956) had tried to 
relate kernicterus to liquor findings and Walker (1957) had used 
spectrophotometry to examine amniotic fluid and claimed 94.9^ 
accuracy it was Liley who rationalised the method and his work has 
largely become the basic point for other workers in this field.
Liley (I96I) showed that the absorption peak at 450n in the 
absorption curve increased in the presence of haemolytic anaemia 
but the significance of this value changed with maturity. He 
also showed the importance of the stage of pregnancy at which 
amniocentesis is done for the first time and emphasised the need 
for serial readings to show a rise or fall in maxima of the peak 
at 450n and thus obtained a trend which gives a better guide than 
one single reading. These results further suggested a correlation 
between the bilirubin peak at 450n and the cord haemoglobin level 
at delivery provided no more than one week interval elapsed between 
amniocentesis and delivery. In the construction of the absorption 
curve Liley made absorption readings at the following wavelengths;-
350, 365, 380, 390, 4oo, 410, 415, 420, 430, 440, 450, 46o, 4?0, 485, 
500, 515, 530, 540, 555, 570, 585, 600, 620, 640, 670 and 700n.
Liley also plotted the results on semilogarithmic graph paper 
with the optical densities as the ordinate on a logarithmic scale 
and the wavelength on the abscissa on a linear scale. He found
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that the curve of normal liquor amnii was almost a straight line 
on such a graph. The wide range of wavelength at which measure­
ments were made enabled distortion of the curve by the presence of 
oxyhaemoglobin, haemoglobin and methaeraalbumen to be recognised.
The optical density at 450n was measured from a base line drawn 
tangentially to the curve and joining the readings at 365 and 
530n. Measuring from this base line eliminated the effects of 
contaminants such as haemoglobin and methaemalbumen on the peak at 
the 430n wavelength.
In a later paper Liley (196I) related bilirubin estimations 
to maturity and classified the results in a large series according 
to severity producing his classic prediction graph. Variations 
on this graph have been made by different workers but it remains 
the most frequently used reference in liquor examinations. This 
graph was constructed by plotting the observed difference in 
optical density (O.D.D.) on a logarithmic scale on the ordinate 
against weeks of maturity on the abscissa on a linear scale.
In assessing the results Liley found that the severely affected 
infants fell into the upper part of the graph, unaffected or mildly 
affected infants fitted into the lower part while a scatter of cases 
of varying severity from moderate to severe fell into the middle 
part and this group has proved to be the most difficult to assess 
with any accuracy.
He was thus able to divide the graph into three zones by con­
structing two parallel lines joining the points:-
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(a) Optical Density (O.D.) 0.25 at 27 weeks* maturity with
O.D. at 0.085 at 40 weeks
and
(b) O.D. 0.059 at 27 weeks* maturity with O.D. 0.02 at 40 weeks.
Following Liley*s work many other workers have published 
results on the examination of liquor and its use in prediction of 
the severity of Haemolytic Disease.
Mackay (I96I) presented a series of 223 patients and graded 
the liquor by visual inspection of graphs obtained by spectro­
photometry and related these grades to the cord haemoglobin levels. 
He emphasised the fact that peaks representing pigments other than 
bilirubin existed at 4lO-4l5n (unidentified haempigments), 415,
540 and 575n (oxyhaemoglobin) and 630n (methaemalbumen) and that 
the presence of these in liquor amnii can affect the shape of the 
curve and perhaps mask and distort the peak at 450n. (This is 
illustrated in Graph 1 and VI). Macltay carried out amniocentesis 
initially at 28 weeks and later at 33 weelcs.
There were many other studies carried out in the few years 
following Liley*s papers (Walker, Fairweather and Knox, 1964;
Alvey, 1964; Robertson, 1964).
One of the most useful studies was that of Freda (I965). He 
graded curves obtained from liquor amnii into four degrees of 
severity according to the optical density difference (O.D.D.) as 
follows:-
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density values at k^Qn
1 +  0 —  0# 2
2 + 0,2 0.33
3 + 0,33 - 0.7
4 + 0.7 or higher
The implications and actions which Freda suggested, based on 
his grades of severity were as follows:-
GRADE 1 4
Repeat amniocentesis at 10 day intervals for last 6 weeks of pregnancy. 
GRADE 2 +
Repeat weekly amniocentesis. Baby Rhesus positive but no immediate 
danger.
GRADE 3 +
Baby Rhesus positive and some degree of circulatory failure present.
If at 32 weeks' maturity deliver the patient.
GRADE 4 +
Impending foetal death usually within one week. No intervention of 
any value at this stage.
Freda at this time made the important point that the optical 
density difference height of the bilirubin peak (O.D.D.) was only 
an assessment of the foetus at that stage in its maturity.
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Of the papers published in the late 1960*s one of the most 
attractive is that of Whitfield, Neely and Telford (I968). In 
this study, which is based on the work of Liley, they suggest an 
’’action line" superimposed on a Liley prediction graph which 
indicates, according to maturity, the necessity of immediate 
delivery or intra-uterine transfusion. The weakness of the 
method, however, is that it depends on the extrapolation of the 
trend of liquor findings derived from as little as two estimations.
This is by no means as predictable as these authors suggest or 
alternatively it would involve the repetition of amniocentesis 
many more times. (This graph is shown on Page 84).
Since the procedure of amniocentesis has now been accepted as 
routine practice it is inevitable that the study of liquor amnii will 
become more detailed and further information will be obtained.
Another approach in the study of liquor amnii has been the 
estimation of Rhesus antibody titres in the liquor (Hoffbauer, 196?; 
Murray, 1969; Usategui-Gomez and Stearns, I969; Usategui-Gomez,
Stearns and Toolan, 1970). It would appear that this line of 
investigation will be a valuable adjunct to the conventional spectro- 
photometric examination of liquor.
Hoffbauer and Geburtsh (1967) simply related the presence of anti­
bodies in the liquor amnii to the degree of severity of Haemolytic 
Disease of the babies delivered. He found a higher mortality and 
higher percentage of severely affected infants in cases where antibodies 
had been found in liquor. Murray (1969) reported a series of liquors 
in which Rhesus antibodies were found. She correlated the
32,
titre of these liquor antibodies to that of the maternal serum 
using the indirect antiglobulin technique. This latter she said 
usually correlates to the severity of Haemolytic Disease, although 
exceptions do occur. Murray also pointed out the importance of 
using the sensitive "papainised cell" technique for the titration 
of antibodies in liquor araniij to detect small amounts.
In 33 pregnancies Usategui-Gomez and Stearns (I969) showed 
that the maternal indirect antiglobulin antibody titre was related 
only to amniotic fluid titre only in so far as it determined the 
maximum found in the latter. In a later paper Usategui-Gomez, 
Stearns and Toolan (1969) found that there was great variation in 
the amount of antibody reaching the liquor amnii but they concluded 
that the Rhesus antibody titre of the amniotic fluid might be an 
indication of the effective level of antibody reaching the foetus. 
They further concluded that in their series where the amniotic fluid 
titre was I/I6 or more an affected child was delivered and in all 
cases where the titre was 1/32 or over the infants were all severely 
affected. They indicated that the level of antibody in the liquor 
amnii may be of use in the more accurate assessment of those cases 
which fall into the indeterminate zone 11 of Liley*s prediction 
graph.
At present a study is being carried out in Glasgow and West of 
Scotland Regional Transfusion Centre investigating further the value 
of amniotic fluid antibodies with the additional parameter of 
quantitative antibody measurement using the auto-analysor technique. 
The series, while encouraging, is not yet large enough to give 
significant results (Mitchell, 1970).
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Further benefits arising from the availability of amniotic 
fluid are the recent studies such as sex determination of the 
foetus from cells in the liquor amnii by Nelson and Emery (1969). 
This could be of great importance in the inheritance of sex-linked 
disorders where, for instance, a male foetus might have a serious 
sex-linked recessive disorder such as Duchenne muscular dystrophy.
To the parents of such a foetus, termination of pregnancy can now 
be offered.
True estimation of maturity in a patient who is uncertain of 
her last menstrual period is often difficult. An attempt has been 
made by Anderson and Griffiths (1968) to estimate maturity by stain­
ing of cells present in liquor amnii which are thought to be from 
the foetal sebaceous glands and which appear in the liquor late in 
pregnancy. These contain fat droplets which stain orange with Nile 
Blue Sulphate. This technique, however, only appears to be of 
value in the last 4-6 weeks of pregnancy and is of little help in 
the mid-trimester and early third trimester when it can be difficult 
to make an accurate clinical estimation of maturity.
Amniography, the technique of injecting radio-opaque material 
into the amniotic sac and followed by x-ray examination, may give 
useful information on the stage of the foetus (Queenan, Von Gal and 
Kubarych, 1969). The displacement of the radio-opaque medium by 
the foetal soft tissues provides an excellent means of measuring 
the amount of foetal oedema. The features which can be evaluated 
are scalp oedema, ingestion of the radio-opaque medium, foetal 
attitude, protruberance of the abdomen and the scapular sign. The 
most important of these are scalp thickness, evidence of foetal 
swallowing and the scapular sign. Information about the volume
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of amniotic fluid and size and situation of the placenta may also 
be obtained from the amniogram.
EXAMINATION USED IN THIS SERIES
A decision to perform amniocentesis on a patient is made on either 
or both of two findings:- ,
(1) An antibody level of I/I6 or greater by the indirect antiglobulin
technique•
(2) A previous history of a severely affected baby.
If amniocentesis is carried out on antibody levels alone it is 
done at 29 and 31 weeks' gestation and repeated if necessary. Where 
there is a previous history of a severely affected baby, amniocentesis
is carried out at 25 weeks' gestation and repeated at one or two weekly
intervals as indicated. It may be necessary to make as many as 4 or 
5 serial estimations at one or two weekly intervals so that the values 
obtained may be plotted on a Liley type prediction graph. Such 
results are useful in establishing whether the situation has changed 
and so indicates the trend of events. An occasional single late 
amniocentesis is carried out on patients who have been referred late
i.e. at 35-55 weeks' gestation and who have no previous history avail­
able. As Liley (I96I) found, however, these late single specimens 
can sometimes be misleading.
The specimens are obtained as described previously (Page 36) 
and centrifuged immediately in the hospital laboratory. The 
supernatant is recovered and placed in a sterile universal container 
protected from light. The spun deposit is similarly protected from
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light and preserved for possible later examination e.g. blood 
grouping of red cells if present.
On arrival at the Regional Transfusion Centre Laboratory the 
specimen is again centrifuged and the supernatant recovered. If 
the liquor is cloudy it is filtered through a cellulose acetate 
filter using a small centrifugal filter unit. Asbestos filter 
pads are avoided because it was found that there was some loss of 
bilirubin by absorption in the asbestos pad. (Graph VI - Page 86).
SPECTROSCOPIC EXAMINATION
The liquor is scanned on a Unicam S.P. 500 spectrophotometer 
over the range of wavelength 350n - ?00n. Readings are taken at 
5n intervals up to 600n and thereafter at 20n intervals unless the 
liquor has a brown tinge and the presence of methaemalbumen is 
suspected. If methaemalbumen is suspected the liquor is scanned 
at 5n intervals to 640n and thereafter at 20n intervals to 700n.
A graph is drawn on semi-logarithmic graph paper with the 
optical density on a logarithmic scale on the ordinate and the 
wavelength on a linear scale on the abscissa. A base line is 
drawn joining the points on the curve at 600n and 520n and this 
straight line is projected back to cut the 450n ordinate. The 
difference in optical density between the point at which this line 
cuts the 450n ordinate to the point on the curve at 450n is measured. 
This is rather loosely called the height at 450n or optical density 
difference (O.D.D.) and is used as a measure of the concentration 
of bilirubin in the liquor. (This is illustrated on Graph Vll).
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As previously stated (Page 49) the presence of haemolgobin 
(absorption maxima 4l5n, 540n, 575%) causes distortion of the 
curve. Using Liley's method for determination of O.D.D. (Page 47) 
it was found that chemical findings in the first series of 50 cases 
did not fit well on Liley's prediction graph and this was attributed 
to the effects of contamination of the liquor with haemoglobin 
pigments.
A series of artificial mixtures of bilirubin and haemoglobin 
were examined by spectrophotometer and from these experiments the 
base line drawn as described above appeared to give recovery results 
for added bilirubin with greater accuracy than the original Liley 
line and in addition there was a better correlation with the clinical 
findings in the 50 cases then under review. (Graphs 1 and Vlll).
CLASSIFICATION
Data for O.D.D. for 50 cases were plotted as ordinates on a 
semi-logaritlimic scale against v/eeks of maturity on a linear scale 
as abscissa and graded for severity by the use of the three zones 
as described by Liley.
In this series the correlation of these observations to clinical 
assessment was not as good as expected. A better correlation
was obtained by drawing the two parallel lines at the following 
positions:-
(l) Upper line from optical density at 0.2 at 26 weeks to optical
density 0.09 at 40 weeks.
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(2) Lower line from optical density at O.O78 at 26 weeks to
optical density 0.034 at 40 weeks.
If the liquor samples are taken earlier than 26 weeks these 
lines can be projected back to the ordinate axisj parallel to the 
abscissa.
As used by Liley the O.D.D. at 450n which lie above the upper 
line indicate a severely affected baby and the possibility of intra­
uterine transfusion or early delivery must be considered. Those in 
the middle zone are considered to be moderately affected - perhaps 
requiring induction at 37 or 38 weeks with the possibility of an 
exchange transfusion being necessary - but not in danger of intra­
uterine death. Those below the lower line are considered to be 
mildly affected or unaffected.
As previously stated, where serial determinations were made, 
close attention is paid to the trend of the readings as well as to 
the actual O.D.D. values.
FURTHER OBSERVATIONS CM LIQUOR SPECIMENS
Various workers, Fleming, Wolffe, Murray (I963); Bjerre, Gold, 
Wilson, Doran (I968) and Connon (I969) have proposed formulae from 
which the concentration of bilirubin in liquor can be calculated in 
mgm.ï^  by the use of spectrophotometry. These formulae usually 
include factors to correct for the effect of haemoglobin, met­
haemalbumen and turbidity. Results using such formulae are some­
times referred to as "Calculated Bilirubin".
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The formula suggested by Fleming, Wolffe and Murray (19&5) 
is as follows
1.25 X (O.D.460) - 0.91 X (O.D.576) - 1.15 x (O.D.623) + O.ll x (o.D.700)
Factor for Factor for Factor for Factor for
bilirubin haemolgobin methaemalbumen turbidity
This formula gives the bilirubin level in milligrammes percent 
and as with the O.D.D. at 450n the results can be classified into 
zones.
This calculation is done routinely on all specimens of liquor 
as an additional check. The total protein is also estimated by 
the Biuret method but this is of limited value.
Recently, as suggested by Murray (1969); Usategui-Gomez, Stearns 
and Toolan (I969), the remainder of the specimen is being examined 
for the presence of Rhesus antibodies and the anti D content estimated 
in microgrammes by the automated technique. To date there is
insufficient data available for discussion of the value of this 
parameter.
RESULTS
The introduction of amniocentesis and the study of liquor
59.
amnii has produced an invaluable tool for the antenatal 
prediction of Haemolytic Disease of the Newborn, Initially 
the liquor findings were correlated with the clinical assessment 
based on Liley*s work. Results showed a l/% error. A number 
of predictions by O.D.D. and by clinical results did not agree 
in certain cases classified as intermediate*
The main difficulty arose in classification of the baby itself. 
Classification of the baby's clinical condition is largely subjective. 
In addition the levels of haemoglobin and bilirubin in cord blood 
used for the classification of mild, moderate and severely affected 
babies vary a great deal from worker to worker (Liley, I96I;
Queenan, 1969; Robertson, 1969; Walker, Fairweather and Jones,
1964).
If classification by treatment of the baby was used then in 
this series the situation was even more complicated by a change in 
Paediatric policy which took place during the course of this 
investigation. In the early part of the series, exchange trans­
fusion was carried out soon after birth on a fixed basis of cord 
haemoglobin of 12 gm.$ or less and/or a cord bilirubin of 3*5 mgra.^ o 
or more. Thereafter a policy of "wait and see" was adopted, 
based on withholding exchange transfusion if the cord haemoglobin 
was 10 gm.^ or over and/or cord bilirubin was 3 mgm.^ or less.
Exchange transfusion was started only when the haemoglobin fell 
below 10 gm.^ or bilirubin rose to 18-20 mgm*%. Several of these 
babies treated by the "wait and see" method required 2 - 3  exchange 
transfusions because of developing anaemia and/or hyperbilirubinaemia. 
Such an infant could be classed as severely affected, when on the
6o.
basis of cord blood findings at birth, it would be classed as 
mild or moderate.
Classification or assessment is made difficult because of 
the many variables which exist e.g. the maturity of the baby and 
hence its ability to cope with the haemolysis of red cells and 
hyperbilirubinaemia, activity of antibody present in the baby's 
blood, activity of the haemopoetic tissue etc.
Looking at the picture as a whole it was concluded that in 
fact three stages capable of assessment are present in Haemolytic 
Disease - the antenatal stage as judged by liquor amnii exam­
ination; the immediate stage at birth judged by clinical examination 
and cord blood levels of haemoglobin and bilirubin of which haemo­
globin is the more important,and the later postnatal stage of hyper­
bilirubinaemia with the danger of kernicterus. This last stage 
cannot be predicted accurately from liquor amnii examination.
THE CORD BLOOD FACTOR
It was appreciated that many severely affected babies with a 
low cord haemoglobin often have relatively low cord bilirubin. 
Bilirubin is a product of red cell haemolysis and antenatally 
excess bilirubin is cleared by the placenta. This may account 
for some low bilirubin levels at birth. If it is accepted that 
the level of haemoglobin at birth is a reflection of the rate of 
breakdown of haemoglobin it is possible that there is, in fact, 
some real relationship between cord haemoglobin and cord bilirubin 
at birth.
6l*
It was decided, therefore, to calculate for the cases under 
review the ratio cord haemoglobin (gm.^)/cord bilirubin (mgm.%)* For 
convenience this figure has been called the Cord Blood Factor (C.B.F.),
Table 1 shows the cord blood findings and G.B.F. for the series of 
173 cases. It is felt that this parameter gives a useful indication of 
the conditions existing inthe infant's blood at birth and appears to 
correlate well with the liquor findings when the C.B.F. is divided into 
mild, moderate and severe sections as is the O.D.D. of the liquor find­
ings.
The C.B.F. values corresponding to liquor mild, moderate and severe 
divisions are as follows
Mild - Over 3
Moderate - 1 - 3
Severe - Under 1
The haemoglobin values for the baby are taken as follows:-     ■■hmmiwi imi im **
Mild - Over 12 gm.
Moderate - 10 - 12 gm.
Severe - Under 10 gm.
The bilirubin values for the baby are as follows:-
Mild - 3*5 mgm. or less
Moderate - 3*5 mgm. - 5 mgm.
Severe - Over 3 mgm.
"Over" prediction was said to occur if the liquor prediction was 
more severe than the baby judged by the above parameters and "under" 
prediction if it was less severe than the baby judged by these 
parameters.
TABLE 1
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Baby No, Cord Haem, Cord Bil. Cord Factor Liquor Prediction
1 16.2 3.2 3.1 Mild
2 9.0 4.2 2.1 Mod.
3 16.0 3.1 3.2 Mild
4 18.0 2.3 7.8 Mild
5 17.0 4.0 4.3 Mod
6 l4.4 6.9 2.1 Mod
7 15.7 6.1 2.6 Mild
8 7.2 4.3 1.7 Mod.
9 16.2 3.6 4.3 Mild
10 13.6 2.3 3.4 Mild
11 13.6 1.4 9.7 Mild
12 6.2 3.8 1.1 Severe
13 11.0 3.3 2.1 Mod.
14 13.6 1.2 11.3 Mild
15 19.6 1.9 10.3 Mild
16 6.3 6.2 1.0 Mild
17 9.8 4.3 2.2 Mod,
18 12.0 4.3 2.7 Mod.
19 13.0 2.7 3.6 Mild
20 13.7 2.0 6.9 Mild
21 9.2 2.0 4.6 Mild
22 13.6 1.9 7.2 Mild
23 4.0 6.2 0.63 Severe
24 16.2 2.6 6.2 Mild
23 10.3 2.6 4*0 Mild
26 6.7 3.9 1.7 Mod.
27 3.6 7.9 0.6 Severe
28 14.3 3.7 3.9 Mild
29 14.0 2.7 3.2 Mild
30 9.6 6.2 1.5 Mild
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TABLE 1 (continued)
iby No. Cord Haem. Cord Bil. Cord Factor Liquor Prec
31 11.8 2.0 5.9 Mild
32 16.4 2.0 8.2 Mild
33 10.3 7.2 1.4 Mod.
34 10.3 4.2 2.5 Mild
35 14.3 5.5 2.7 Mod.
36 10.7 5.6 1.9 Mod.
37 12.5 3.7 3.4 Mild
38 18.0 2.3 7.8 Mild
39 15.6 2.5 6.2 Mild
4o 13.8 3.6 3 .8 Mild
4l 9 .7 3.7 2.6 Mild
42 15.0 1.9 8.0 Mild
43 11.5 2.1 5.5 Mod.
44 11.0 2.2 3.0 Mild
43 16.0 2el 7.6 Mild
46 15.8 0.8 19.8 Mild
47 16.0 1.5 10.7 Mild
48 9 .0 6.0 1.5 Mod.
49 11.2 3.2 3.5 Mild
30 8.9 6.2 1.4 Mod.
31 20.0 4.3 4.7 Mild
32 5 .5 5 .9 0.9 Mild
53 13.8 2.1 6.6 Mild
54 14.0 3.2 4.4 Mild
55 13.0 3.4 3.8 Mild
56 14.0 2.8 5.7 Mild
57 14.4 4.4 3.3 Mild
58 12.6 2.8 4.3 Mild
59 15.8 2.1 7.5 Mild
6o 14.6 3.6 4.1 Mild
TABLE 1 (continued)
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Baby No. Cord Haem. Cord Bil. Cord Factor Liquor Prediction
61 14.8 2.2 6.7 Mild
62 16.8 2.5 6.7 Mild
63 17.6 2.3 7.0 Mild
64 10.3 3.0 2.1 Mild
65 12-6 2.6 4.8 Mild
66 13.4 3.4 3.9 Mild
67 13*6 2.6 3.2 Mild
68 13.4 2.8 3.5 Mild
69 20.0 1.2 16.7 Mild
70 17.3 2.9 6.0 Mild
71 11.5 2.9 4.0 Mod.
72 17.0 1.7 10.0 Mild
73 18.4 2.3 7.4 Mild
74 6.8 3.6 1.2 Severe
73 13.0 1.7 8.8 Mild
76 13.2 4.8 2.8 Mod.
77 16.2 1.3 10.8 Mild
78 17.8 1.8 10.0 Mild
79 9.0 3.0 1.8 Mod.
80 13.9 3.9 3.3 Mild
81 17.0 3.6 4.7 Mild
82 11.6 3.6 3.2 Mod.
83 9.7 4.2 2.3 Mod*
84 12.8 3.4 3.8 Mild
83 13.0 2.0 6.5 Mild
86 18.0 1.6 11.3 Mild
87 13.0 2.8 4.6 Mild
88 3.3 6.3 0.9 Mod.
89 14.6 1.8 8.1 Mild
90 10.0 8.7 1.2 Mod.
TABLE 1 (continued)
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Baby No. Cord Haem. Cord Bil. Cord Factor Liquor Prediction
91 10.0 3.1 2.0 Mild
92 10.7 3.3 2.0 Mild
95 16.0 3.3 4.9 Mod®
94 14.8 1.3 9.9 Mild
93 13.2 8.3 1.6 Mod.
96 14.0 6.3 2.2 Mod.
97 16.6 2.1 7.9 Mild
98 16.0 4.0 4.0 Mild
99 12.1 3.0 4.3 Mild
100 l4.0 1.9 7.4 Mild
101 13.7 2.6 4.4 Mild
102 2.3 3-6 0.64 Severe
105 14.4 2.3 3.7 Mild
104 11.2 3.4 3.3 Mild
103 14.8 2.8 3.3 Mild
106 9.4 9.3 1.0 Mod.
107 12.8 3.8 3.4 Mild
108 10.8 4.5 2.1 Mod.
109 12.0 4.7 2.6 Mod.
110 13.4 2.4 5.3 Mild
111 10.7 3.1 2.1 Mod.
112 13.2 1.8 8.5 Mild
113 18.6 2.7 6.9 Mild
114 8.4 8.6 0.9 Mod.
113 11.6 4.3 2.7 Mild
116 7.7 6.7 1.1 Mod.
117 10.2 8.7 1.0 Mod.
118 10.4 1.2 1.2 Mod.
119 13.8 2.3 6.9 Mod.
120 19*3 2.8 6.9 Mild
TABLE 1 (continued)
66.
Baby No. Cord Haem* Cord Bil, Cord Factor Liquor Prediction
121 2.3 3.6 0.69 Severe
122 16.8 2.6 6.3 Mild
123 3.3 6.7 0.82 Severe
124 6.1 6.8 0.89 Severe
123 14.0 3.0 4.7 Mild
126 12.0 3.3 3.4 Mild
127 18.0 4.2 4.3 Mod.
128 18.0 2.0 9.0 Mild
129 18.8 3.0 6.3 Mild
130 17.9 2.6 6.9 Mild
131 18.0 3.8 4.7 Mild
132 19.6 1.3 13.0 Mild
133 13.4 2.8 4.8 Mild
134 10.2 6.9 1.5 Mod.
133 13.8 4.0 3.3 Mild
136 3.2 3.2 0.61 Severe
137 14.3 3.6 4.0 Mild
138 l4.0 3.7 3.8 Mild
139 16.7 2.0 8.4 Mild
l4o 14.8 4.9 3.0 Mild
l4l 13.1 2.3 6.0 Mild
142 10.2 4.3 2.3 Mod.
143 13.7 2.3 6.3 Mild
144 13.3 4.1 3.2 Mild
143 16,8 2.0 8.4 Mild
l46 11.1 6.2 1.8 Mod.
147 16.0 2.3 6.4 Mod.
148 8.6 2.7 3.2 Mild
149 13.2 3.8 3.5 Mild
150 13.0 4.4 2.9 Mild
TABLE 1 (continued)
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Baby No. Gord Haem. Gord Bil. Gord Factor Liquor Prediction
151 l4.o 2.8 3.0 Mild
152 12.0 4.3 2.7 Mild
153 14.3 2.3 6.2 Mild
134 13.8 2.3 3.3 Mild
153 18.0 2.3 7.8 Mild
136 16.3 1.3 9.9 Mild
137 14.3 6.4 2.3 Mild
138 18.0 1.8 10.0 Mild
139 17.3 1.3 11.6 Mild
160 9.8 3.3 1.8 Mod.
161 20.0 1.8 16.4 Mild
162 19.3 2.7 7.1 Mild
163 14.8 3.0 4.9 Mild
164 12.0 4.9 2.4 Mild
165 9.1 7.1 1.3 Mild
166 16.0 2.3 6.9 Mild
167 12.3 3.0 4.2 Mild
168 13.6 1.8 7.3 Mild
169 14.3 2.0 7.2 Mild
170 l4.o 2.9 4.8 Mild
171 3.0 4.2 0.7 Severe
172 18.0 2.0 9.0 Mild
173 19.8 2.0 9.0 Mild
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Table No. 11 shows the cord blood findings in relation to 
liquor prediction in the 173 cases. In addition it shows the 
range of cord haemoglobin, cord bilirubin and cord factor, and 
indicates the percentage of cases in each range. The mean and 
the standard deviations are shown* These findings are further 
illustrated in the column diagrams on Pages 71» 72, 73 and 74,
TABIJ] 11 69#
CORD BLOOD FINDINGS IN RELATION TO LIQÜQE PREDICTIONS IN 173 CASES
CORD HB. (Rms.%) 
Liquor 
Range Mild Mod. Sev.
CORD BILIRDBIN
Liquor 
Range Mild Mod. Sev.
CORD FACTOR
Range
Liquor 
Mild Mod. Sev.
0-0.9 — - - 0 —0.4 — — —
1-1.9 - - — 0.5-0.9 1 - —
2-2.9 - — 2 1.0—1.4 3 1 -
3-3.9 - - 2 1.5-1.9 19 - -
4-4.9 — - 2.0—2.4 23 2 —
5-5.9 1 1 2 ! 2.5-2.9 31 2 —
6-6.9 1 1 3 3.0-3.4 13 1 —
7-7.9 — 2 — 3.3-3.9 14 2 2
8-8.9 1 2 - 4.0-4.4 8 6 1
9-9.9 4 7 - 4.5-4.9 3 3 -
10-10.9 3 9 - 5.0-5.4 3 3 1
11-11.9 3 3 - 5.5-3.9 1 3 2
12-12.9 10 2 - 6.0-6.4 4 4 1
13-15.9 21 2 — 6.5-6.9 - 3 2
l4—i4*9 22 3 - 7.0-7.4 1 2 —
15-13.9 12 1 — 7.3-7.9 — 1
16-16.9 16 2 — 8.0-8.4 1 —
17-17.9 7 1 — 8.5-8.9 - 3 —
18-18.9 11 1 - 9.0—9.4 1 —
19-19.9 3 — - 9.3-9.9 — — -
20-20.9
21-21.9
3 — :
10.0-10.4 — — —
0 —0.4" —
0.5-
1.0-
1.5-
2.0- 
2.5"
5.0-
3.5-
4-.0-
4.5-
5.0- 
5.3-
6 * 0-
6.5-
7.0-
7.5-
8.0-
8.5- 
9.0-
9.5-
10.4-
10.5- 
11.0-
11.5- 
12.0-
12.5- 
13.0-
■0.9
1.4
•1.9 
-2.4
2.9
3.4
3.9
'4.4 
'4.9 11 
■3.4 9
■3.9 6
-6.4 7
1
2
1
6
3
8
30
9
■6.9 10 
•7.4 6 
■7.9
'8.4
•8.9
9.4
■9.9
•10.4
'10.9
'11.4 
'11.9 
'12. 4
■12.9
■13.4
16.0-16.4 1 
16.5-16.9 1
19.3-20.0 1
2
7
9
9
4
1
3
1
1
1
1
8
2
TOTALS
MEAN
S.D.
124
l4.6
2.8
39 10
11.2 4.5 
2.8 1.6
TOTALS
MEAN
S.D.
124 39 10
2.9 3.2 5.6 
1.2 1.9 1.4
TOTALS
MEAN
S.D.
124 39 10 ■
5.0 2.4 0.8 ’
3.1 1.5 0.2
RANGE (MEAN t 2 S.D.) I RANGE (MEAN + 2 S.D.) RANGE (MEAN + 2 S.D.)
MILD 9.0 - 20.2 MILD 0.5 - 5.3 MILD 0 - 12.2
MOD. 3.6 - 16.8 MOD. 1.4 — 9.0 :MOD. 0 - 5.4
SEV. 1.3 - 7.7 SEV. 2.8 - 8*4 SEV. 0.4 — 1.2
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Figures 1, 11 and 111 are diagrams which show the frequency 
distribution of the 173 cases of liquor prediction related to cord 
haemoglobin gms. percent, cord bilirubin mgm. percent and cord blood 
factor respectively.
The key to these figures is to be found on Figure 111.
Figure IV is a diagrammatic illustration of the cord blood 
findings in relation to liquor prediction showing the mean + 1 and 2 
standard deviations.
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75.
Since Liley in I96I related liquor aranii bilirubin to maturity 
in his prediction graph this has been the most reliable parameter in 
the antenatal assessment of the severity of hhesus isoimmunization as 
affecting the baby. The assessment of the severity of Haemolytic 
Disease at birth has been a most difficult problem and Liley found 
the haemoglobin status of the baby at birth correlated best with 
his liquor prediction. This, however, gave a XT/o error. In this 
series liquor amnii predictions have been correlated with cord 
haemoglobin, cord bilirubin and a new cord blood factor. The errors 
in prediction in the series as seen in Table 111 have been as follows:- 
23*1^ correlated with haemoglobin; 36.4fo correlated with bilirubin 
and 13.6^  correlated with cord blood factor.
From the above figures it is confirmed that liquor aranii exam­
ination is of great value in prediction of severity of Haemolytic 
Disease of the Newborn. It is suggested cord blood factor correlates 
best with that prediction and appears to be a useful parameter in the 
assessment of the baby at birth.
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STILLBIRTHS AND NEONATAL DEATHS IN THE AMNIOCENTESIS CASES
(See Table IV).
In the 192 cases of amniocentesis there were I3 stillbirths 
(7#%) and 11 neonatal deaths (5.7^0 • The 192 cases are the 
more severely affected cases out of a total of 917 excluding the 
26 cases treated by intra-uterine transfusion which are dealt with 
separately. The results are shown in Table IV.
Of the stillbirths, 10 had hydrops foetalis and in all these 
cases the liquor prediction was severe. Three cases had an 
unexplained intra-uterine death. The liquor prediction in these 
was mild. In 2 cases with a moderate prediction the cause of 
death was antepartum haemorrhage.
Of the neonatal deaths, 8 babies had hydrops foetalis and all 
of these had severe liquor predictions. Two babies died of 
Respiratory Distress Syndrome. One of these had a mild liquor 
prediction and did not require treatment for Haemolytic Disease.
The other had a severe liquor prediction and had two exchange trans­
fusions. One baby which had a moderate liquor prediction died 
unexpectedly during exchange transfusion.
There are 19 more cases discussed above than in the part dealing 
with cord blood findings because in these 19 cases cord blood exam­
ination was not possible.
TABLE
Stillbirths and Neonatal Deaths in the Amniocentesis Cases
78,
No. Cause Liq. Hb. Bil. C.B.F. S.B. N.N.3
1 Hydrops Severe Severe M & S Mod. — 1
2 Hydrops Severe Severe M & S S 1 -
3 Exchange
death
Mod. Mod. M & S Mod. — 1
k Hydrops Severe Severe M & S Mod. — 1
3 Hydrops Severe Severe Mild S — 1
6 Hydrops Severe Severe Mild S - 1
7 Hydrops Severe N.D. — — 1 -
8 Hydrops Severe N.D. - - 1 -
9 Hydrops Severe - - — 1 -
10 Hydrops Severe — - - 1 —
11 Hydrops Severe Severe M 8c S s - 1
12 Hydrops Severe - - - 1 -
13 Hydrops Severe — - — 1 —
14 A.P.H. Mod. - - - 1 -
13 Hydrops Severe - - — — 1
16 R.D.S. Mild Mod. M & S Mod. *• 1
17 Hydrops Severe - — — 1 -
18 Hydrops Severe Severe M 8c S S - 1
19 A.P.H. Mod. — - 1 —
20 I.U.D.
unexplained
Mild w — 1
21 Hydrops Severe — - - 1 -
22 I.U.D.
in labour 
unexplained
Mild 1
23 I.U.D.
unexplained
Mild — 1
24 Hydrops Severe — - — 1 —
23 2 exchange 
R.D.S.
Severe Severe M 8c S s 1
- 26 Hydrops Severe Severe Mild s 1
The key to this table is overleaf.
79.
KEY; R.D.S. — Respiratory Distress Syndrome
M & S - Moderate and Severe
I.U.D. - Intra-uterine death
C.B.F. — Cord Blood Factor
A.P.H. - Ante-parturn haemorrhage
N.N.D. — Neonatal death
S.B. - Stillbirth
N.D. - Not done
Mod. - Moderate
Hb. Haemoglobin
Liq. - Liquor amnii
80.
SUMMARY
The study of liquor amnii has now become firmly established in 
the management of the Rhesus isoimmunized pregnant woman. It should 
not, however, be used indiscriminately. It does carry a slight, but 
definite, risk to mother and foetus and does not entirely replace the 
conventional standards of prediction of the degree of severity as 
affecting the baby. The most rewarding use of liquor examination is 
to detect the severely affected baby and the mild or unaffected baby.
In the former case action can be planned accordingly and the baby given 
the best possible chance of survival. In the latter case accurate 
prediction can prevent interference, with a potentially disastrous 
result, in a Rhesus negative baby. It is fortunate that liquor exam­
inations, by whatever method * spectrophotometric or biochemical, 
are most reliable in these two extremes.
Where the prediction by liquor examination lies in the middle 
zone the picture is less accurate, but much additional help can be 
obtained by using the longer established methods of prediction - 
maternal antibody titres and now antibody content, previous history 
or pattern of disease and zygosity of the husband. There is no doubt, 
however, that liquor amnii examination is the best single diagnostic 
aid provided its limitations are noted, particularly that it reveals 
the state of the baby only at the time of amniocentesis.
It is true to say that even with amniocentesis, and the other aids 
to prognosis, the eventual survival of many affected babies depends on 
intelligent interpretation of these parameters and previous experience.
In the present series it was found that liquor amnii examination 
was a most valuable prognostic aid for the antenatal management of 
Rhesus sensitized patients.
GRAPH 1 81.
REMOO'UOlilN
^  HéEMOO-LOB
T Perk
0-1
09
0-7
0*0
iBiN
0 3
KfoRIIRL : L iq u o p j j
pAEMlpG-LOBINt
0*1 o^osso 700400
WWV»L.IHOTri
82.
GRAPH 11
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This is a Liley prediction graph showing the effect of meconium in the
liquor amnii and its decrease.
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I N T R A-U T E R I N E  T R A N S F U S I O N
The introduction of the technique of Intra-uterine Transfusion 
by Iiiley in 1963 shed the first ray of light on the dark obstetric 
future of the Rhesus immunized woman, with a Rhesus positive homo­
zygous husband who had lost one or more babies from Haemolytic 
Disease of the Newborn* By making use of the fact, recognised in 
1863 and first used clinically in I873, (Friesen, R.F., Bowman, J.M.
1966) that intact red blood cells are absorbed from the peritoneal 
cavity via the diaphragmatic lymphatics and the thoracic duct to the 
venous circulation, it is possible to transfuse the foetus and treat 
the developing intra-uteririe haemolytic anaemia thus preventing cardiac 
failure - the cause of intra-uterine death. Since I963 this technique 
has been accepted where indicated as part of the management of the 
sensitized mother (Liley, 1964; Karnicki, 1966; Queenan, 1969; 
McCrostie, 1964; Fairweather, Tacchi, Coxon, Hughes, Murray and 
Walker, 1967).
Originally Liley thought that red cell absorption from the foetal 
peritoneal cavity took place at the rate of 1 ^  per day and was complete 
eight to ten days after foetal transfusion* Creasman, Duggan and 
Lund (1966), by the use of chromium labelled cells, showed that there 
was almost 100^ 6 absorption in three days between intra-uterine trans­
fusion and delivery. Intra-uterine transfusion is not, however,
without risk to both mother and baby. It requires skilled operators 
and a close liaison between obstetrician, paediatrician, radiologist 
and laboratory worker. Experience and skill is only acquired with
time and a series of cases. This is best developed by one team in
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one unit and such cases requiring active treatment should be 
centralised in hospital where these teams are readily available.
MATERNAL RISKS
The dangers to the mother are varied. Placental separation 
and antepartum haemorrhage come immediately to mind in an operation 
of this type particularly when the placenta lies anteriorly and is 
in danger of being pierced by the needle. Infection is an ever 
present risk, especially when intra-uterine death follows rapidly 
after intra-uterine transfusion. Such a complication was reported 
by Horger and Hutchinson (I969) when hysterectomy became necessary 
following infection of the foetus and uterus by a gas-producing 
micrococcus. Infection may also take the form of amnionitis or 
peritonitis if amniotic fluid leaks back along the needle track. 
Friesen, Bov/rnan, Barnes, Grewar, Mclnnis and Bowman (I967) report a 
case in which liquor aranii may have reached the maternal circulation 
from a false space when the membranes were partially detached from 
the uterine wall. As this fluid is rich in thromboplastic 
substances it could cause intravenous clotting with potential danger 
to the mother’s life. Further anxiety may be caused to the operator
by the knowledge that the mother may have had a previous Caesarean 
Section and thus the uterus is scarred and weakened. A late maternal 
risk, namely serum hepatitis, has been reported following foetal trans­
fusion (Bishop, Weber and Israel, 1967; Wade, Ogden, Anderson and 
Davis, 1969).
FOETAL RISK
Many of the early fears of intra-uterine transfusion were centred
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on the danger of trauma and haemorrhage in the foetus. Injury 
to the soft tissues - liver, spleen, abdominal and other organs - 
have been reported (Friesen et al, 196? and Fairweather et al, 196?). 
Fairweather and others have reported injection of dye into the plural 
cavity, intestinal lumen, bladder, pericardium and even into the 
spinal canal with a resultant myelogram. If the spleen and liver 
are lacerated these injuries appear to heal well (Karnicki, 1968) 
and do not necessarily affect the outcome of the pregnancy. Karnicki 
(1966) also reports a case where a piece of catheter about 10 centi­
metres in length broke off in the foetal peritoneal cavity and was 
left there with no obvious permanent damage to the child which was 
born alive. Laceration of the umbilical cord has been reported
causing foetal haemorrhage and gas gangrene to both mother and foetus 
(Queenan, I969). Foetal mortality as a direct result of intra­
uterine transfusion has been reported as high as l4.^ to 19.2^ per 
transfusion by Friesen et al (I967).
During intra-uterine transfusion there may be foeto-maternal 
bleeding which may cause further stimulation of antibody production 
in the mother and thus cause a deleterious effect on the foetus. 
According to Liley (1964) this risk is academic. The blood used 
may well cause harmful effects to the foetus - serum hepatitis - as 
previously mentioned, cytomegalic inclusion disease (Karnicki, I968) 
and injection of fresh leucocytes carrying the risk of runt disease 
(Naiman; Plunnet; Destine and Lischner, I966). Depression of 
the foetal marrow may also result from intra-uterine transfusion. 
Schwarz (I967) in a letter to the Lancet reports two cases of apparent
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haemorrhagic diathesis, from which the foetuses died, after trans­
fusion with washed cells. He suggests that as treble washed 
cells are relatively free of all elements except erythrocytes, 
incoaguable haemorrhage in the foetus may be as much a danger as 
runt disease.
INDICATIONS FOR INTRA-UTERINE TRANSFUSION
While broad principles may be followed as a guide for intra­
uterine transfusion each case must be judged on its individual 
merits.
The fundamental parameters leading to a decision to undertake 
intra-uterine transfusion are:-
(1) A history of previous pregnancies in which the foetus was
severely affected by Haemolytic Disease particularly where the outcome
was a stillbirth or neonatal death.
(2) The findings at amniocentesis where the amniotic fluid showed a 
high concentration of bilirubin either by spectrophotometric or bio­
chemical methods - See previous chapter.
(3) The genotype of the husband particularly when he is thought to be
homozygous Rh. D positive. The husband’s genotype is of especial 
importance when the first pregnancy in which antibodies appear is just 
the patient’s second pregnancy. The knowledge that all future
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pregnancies will be affected due to the homozygosity of the father, 
always resulting in a Rhesus positive baby, lends weight to the 
decision for active intervention in such a case where the amniocentesis 
findings and antibody titre indicate a severely affected baby and 
previous history is lacking. These cases carry an %  mortality before 
the 33rd week of pregnancy (Robertson, 1964). The zygosity of the 
father is conversely of value in a case where a woman has a history 
of previously badly affected pregnancies and yet has liquor findings 
suggestive of a mild or unaffected foetus. In this case the knowledge 
that the father is heterozygous Rh. D positive may strongly support the 
diagnosis of an unaffected foetus. The main pitfall in the use of the 
husband’s genotype is where there is an extra-marital liaison - usually 
unlcnown to the obstetrician. It might also be mentioned that unless 
family studies are done the genotype is only a probable one and that 
errors in assumption are not unknown e.g. a CDe/cde genotype may be 
assumed where, in fact, it is CDe/cDe.
(4) ANTIBODY TITRE
With the advent of amniocentesis maternal antibody titre has 
played a slightly lesser role in foetal prognosis in Haemolytic Disease 
of the Newborn. A rising titre of maternal antibody suggests an 
affected foetus, the significant clinical level varying among several 
workers. This is well reviewed by Mollison (I967). Several
factors may influence the rise of antibody titres and thereby 
invalidate the prognosis. The first is the anamnestic rise which
may occur when a woman who has had a previously affected baby carries 
a Rhesus negative foetus. Such rises may be very sharp and reach
levels of 1/8,000 by indirect antiglobulin technique but the answer
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is usually found by liquor amnii examination. Amniocentesis and 
intra-uterine transfusion themselves may cause a fluctuation of 
antibody titre by provoking a foeto-maternal haemorrhage stimulating 
antibody production. This is one of the accepted risks of both 
procedures and is felt to be of little real importance (Walker et al, 
1963). One definite use of antibody titre is to select cases for 
amniocentesis and therefore possible intra-uterine transfusion. In 
this series the antibody level used is I/I6 by indirect antiglobulin 
titre to indicate the necessity for amniocentesis but each laboratory 
has to find its own critical titre.
(3) CLINICAL FINDINGS
While laboratory aids to prognosis are essential the clinical 
findings in potential cases of intra-uterine transfusion are of 
paramount importance. It is accepted by all workers in this field - 
Liley (I963); Queenan (I969); Karnicki (I966); Friesen (I968) 
that the selected time of gestation for intra-uterine transfusion is 
important. Where a stillbirth or neonatal death has resulted from 
a previous pregnancy it is usually necessary to intervene actively at 
an even earlier stage in a subsequent affected pregnancy. Should 
this occur before the 28th week of pregnancy intervention in the form 
of intra-uterine transfusion can be technically very difficult and 
the number of transfusions required may be as many as three or four or 
more, each carrying a l4.^ - 19#^ risk to the foetus (Friesen et al,
1967). In such cases where the signs of likely foetal death from 
Haemolytic Disease e.g. ascites, oedema, appear early i.e. before the 
26th or 28th week, intra-uterine transfusion has a much lesser chance
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of being successful and the clinician may wonder if the maternal 
risk is justified. This point will be further discussed later.
PRACTICAL TECHNIQUES OF INTRA-UTERINE TRANSFUSION 
BLOOD USED
Blood collected in acid citrate dextrose and not more than 48 
hours old is used. Preferrably the blood should be at least 12
hours old to cut down the risk of cytomegalic virus infecting the 
foetus. It is now possible, by testing the chosen blood for 
hepatitis associated antigen to reduce the risk of this particular 
infection in both mother and foetus.
The blood used is Group 0 Rhesus negative cde/cde largely free 
from anti A or anti B haemolysins and is compatible with the mother’s 
serum. Five hundred and forty ml. of blood are centrifuged at 
1,800 revs/min. for half an hour in a Mistral refrigerated centrifuge 
at 4°C. The plasma and buffy coat are then removed and saline 
added till the volume of cells and saline is 3 ^  ml. This is mixed 
well and filtered through a blood giving set. The blood and saline 
mixture is again centrifuged at 1,800 revs/min. for half an hour 
following which the saline and remaining buffy coat are removed.
Fresh saline is added to make up a total volume of 200 ml. approximate­
ly. This gives a concentration of red cells with a haemoglobin of 
20-22 gms.^.
By taking into account the ABO, Rh., MNS, Kidd, Duffy, Lewis and
Scot. med J ., 1967, 12 :277
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S I NCE Liley (1963) published the firsi report on intra-uterine transfusion o f the 
foetus this procedure has been used in a 
number o f centres and the technique has been 
modified in the light o f experience by various 
authors.
As this treatment is now being adopted in 
many units a prelim inary report o f the tech­
nique used by the authors is submitted. This 
technique has been found to simplify the 
procedure, apparently increase its safety, and 
reduce the time involved.
On the day prior to transfusion amniocen­
tesis is carried out and 20 ml. urografin 76 per 
cent is injected into the amniotic cavity.
On the day o f operation the patient is 
sedated with sodium am ytal, 200 mg. and 
Sparine, 50 mg. one hour before operation. 
The procedure takes place on the X -ray table. 
In a patient receiving a first transfusion a 
lateral X -ray  is taken to localise the placenta 
using the ‘water pillow ' technique (Fig. 1). 
A skin marker is now affixed to the abdomen 
in the region o f the umbilicus and the foetus 
is gently palpated.
The abdomen is then prepared with spirit 
and iodine and a sterile improvised grid is 
applied to the abdomen over the uterus as 
suggested by Lees (1966) and the abdomen 
is now draped with a sterile operating sheet.
An antero-posterior X -ray  is taken and the 
plate is studied on the viewing box. A point 
vertically above the urografin shown in the 
foetal bowel below the level o f the foetal liver 
and above the presumed position o f the foetal 
bladder is chosen and its position relative to 
the grid is noted. The size o f the squares on 
the grid is im portant as small squares diminish 
definition in the T .V . m onitor. The optimum  
size is \ \ -2  in. per square (Fig. 2). This point 
is now identified on the mother's abdomen 
and a local anaesthetic is injected into the 
skin and down to the peritoneum. An  
incision about &in. is made over the point 
with a scalpel and the Tuohy 16 gauge 18 cm. 
needle is now passed vertically downwards 
till the foetal abdomen is encountered. Tw o  
assistants, one at the head o f the table and one 
at the side o f the table, guide the operator in 
keeping the needle vertical during insertion.
Fig. 1. Placental localisation film. Fig. 2. Grid localisation o f foetal bowel.
Black, Dempster and MacDougall
When the needle reaches the foetal abdominal 
wall slight resistance is encountered and then 
a distinct ‘give' is felt as it passes into the 
peritoneal cavity.
A Portex intravenous catheter, length 26 in. 
is passed through the Tuohy needle and some 
inches beyond its point. An attempt is made 
to aspirate fluid and if  no liquor amnii can be 
aspirated it is presumed that the catheter is 
now in the foetal peritoneal cavity. Urografin  
76 per cent or Hypaque 45 per cent 3 to 4 ml. 
are injected through the catheter and the 
area is now briefly viewed on the image 
intensifier. I f  the foetal abdomen is not 
clearly outlined a further I to 2 ml. opaque 
medium are injected under vision with the 
image intensifier, i f  the radio opaque sub­
stance remains localised and the curve o f the 
anterior abdomen and diaphragm visualised 
then the catheter is considered to be in the 
foetal peritoneal cavity. In the early cases 
with this technique a further antero-posterior 
X-ray film was taken after the injection o f  
the 3 to 4 ml. urografin or Hypaque (Fig. 3).
According to the m aturity o f the foetus, 
80 to 120 ml. o f warmed, washed packed 
cells o f group O Rhesus negative blood, 
haemoglobin 20 g. per cent, are injected 
using a two-way 10 c.c. syringe. The blood
Fig. 3. Fc>etal abdomen outlined with dye.
is held in a giving set and stand, and as the 
catheter is very fine, it has been found to be 
easier to make the injection through the 
relatively narrow bore o f a 10 c.c. syringe.
A t the end o f the procedure the needle and 
catheter are removed and the abdominal 
wound sealed w ith collodion and a gauze 
swab.
W ith  the technique described it has been 
found possible to carry out the procedure in 
about 30 to 40 minutes. The use o f the grid 
and the vertical insertion o f the needle usually 
enables the target area to be reached at the 
first attempt. One hazard is that an anteriorly  
situated placenta may have to be traversed 
but this is a risk o f all procedures when the 
placenta is so situated.
Radiation dosage is carefully controlled. 
The average screening time with the low  
dosage image intensifier and T .V . m onitor is 
\ \  minutes and average number o f films per 
examination is 2.
Case s
Fifteen patients have been treated by 26 
intra-uterine transfusions, the m aturity o f  
the foetus varying between 26 and 32 weeks. 
The first 5 cases were treated without the 
image intensifier and grid, and only I baby 
survived. The next 10 patients were treated 
using the image intensifier and 8 o f the babies 
have survived. One o f the 2 babies lost, 
died during a second exchange transfusion 
reflecting a hazard o f exchange transfusion 
rather than the severity o f the haemolytic 
disease.
One o f the 15 patients has been counted 
twice as she has been treated in 2 pregnancies 
and the baby has survived on each occasion.
Tw o additional patients are at present 
under treatment.
During the last 12 intra-uterine transfusions 
the grid has been used and this has greatly 
simplified the procedure.
A ( K N O W  L EO C E M E N T .  We are grateful to D r  
R. A. Tennent for his co-operation.
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Kell groups it has been possible to select blood distinguishable 
from the parents and sometimes from another donor used for a 
subsequent transfusion. By using these antigens for identification 
in association with the mixed agglutination technique (Jones and 
Silver, 1958) it has been possible to differentiate donor and foetal 
blood in the baby after delivery. Using the same techniques of 
identification blood which may have escaped into the liquor amnii or 
which may have been retained in the foetal peritoneal cavity may be 
grouped.
The use of maternal blood for transfusing the foetus has been 
described recently by Eyster, Queenan and Haber (1969). This
method eliminates the risk of maternal homologua serum hepatitis 
and isoimmunisation to other blood group factors. The authors 
indicate that neither transfer of maternal Rhesus antibody to the 
foetus nor potential foeto-maternal ABO incompatibility is hazardous 
to the foetus. Precautions in the use of this method are that the 
maternal haematocrit must be 355^  or greater and that no more than 
150 ml. of blood are withdrawn for each transfusion.
TECHNIQUES OF INTRA-UTERINE TRANSFUSION
TRANS-ABDOMINAL TECimiQUE
This is based on the method used by Liley (I963) and is the one 
used in this series. (Black, Dempster and MacDougall, 1967)#
The patient is admitted to hospital on the day prior to the
1 0 1 ,
PLATE 1
Lateral soft tissue x-ray film to show position of placenta 
and depth of radio opaque dye from anterior abdominal wall.
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transfusion and amniocentesis carried out, 20 millilitres of 45^ 
Hypaque being injected into the amniotic cavity. When it is the 
first intra-uterine transfusion to be given, some twelve hours 
later a soft tissue lateral x-ray of the woman is taken to localise 
the placenta. On the day of the transfusion the patient is 
sedated with Sodium Amytal, 200 mgm. and Sparine, 50 mgm. one hour 
before operation and the patient is transferred to the x-ray
department where the transfusion takes place*
PLATE 1
This shows the position of the foetus with the placenta lying 
posteriorly and the dye present in the foetal bowel.
This film helps to give guidance to the depth of the target 
area from the skin of the abdominal wall.
The sophisticated technique of localisation by isotopes and 
thermography are not yet available in Lanarkshire but, due to 
excellent radiology, the localisation of placentae is remarkably 
accurate.
The patient lies supine for 15-20 minutes and then the foetus is
gently palpated. The abdominal skin is then prepared with spirit
and Iodine and a sterile grid of plastic covered wire is applied over 
the uterus as suggested by Lees (1966). The abdomen is now draped 
with a sterile operating sheet.
PLATE 11
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L
This shows grid in position and relation of target area to squares 
in grid.
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PLATE 111
This plate shows the needle and catheter in position with the 
foetal diaphragm and abdominal wall outlined in Hypaque. It also 
shows a marker over the maternal umbilicus which is no longer used,
105.
An antero-posterior x-ray is taken and the plate is studied 
on the viewing box. A point for entry of the Tuohy needle 
judged to be vertically above the Hypaque shown in the foetal bowel, 
allowing for the x-ray distortion, below the level of the foetal 
liver and above the presumed position of the foetal bladder, is 
chosen and its position relative to the grid is noted. The size 
of the squares on the grid are important as small squares diminish 
definition on the Television Monitor. The optimum size is 1^-2 
inches square.
PLATE 11
This shows the grid in position and the relation of the foetal 
abdomen to the squares on the grid.
The selected point is now identified on the mother’s abdomen 
and a local anaesthetic (1^ Lignocaine) is injected into the skin 
and down to the peritoneum. A skin incision of about 1/8 inch 
is made over the point with a scalpel and the Tuohy l6 gauge l8 
centimetre needle is now passed vertically downwards through the 
abdominal incision until the foetal abdomen is encountered. Two 
assistants, one at the head of the table and one at the side of the 
table, guide the operator in keeping the needle vertical during 
insertion. Vi/hen the needle reaches the foetal abdomen slight 
resistance is encountered and then a distinct ’’give” is felt as 
it passes into the foetal peritoneal cavity. There may then be 
a definite movement of the needle indicating foetal protest.
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A Portex intravenous catheter 26 inches in length is passed 
through the Tuohy needle and some inches beyond the needle end.
An attempt is made to aspirate liquor and if no liquor aranii is 
obtained it is presumed that the catheter is now in the foetal 
peritoneal cavity. On occasions when foetal ascites is present 
and the needle is in the peritoneal cavity as much of the ascitic 
fluid is withdrawn as possible. The ascitic fluid is clear and 
very yellow and on the first occasion when it is withdrawn un­
contaminated by blood, is easily distinguished by the naked eye 
from amniotic fluid. Two to three millilitres of k^o Hypaque 
are now injected through the catheter and the area is briefly viewed 
on the image intensifier. If the foetal peritoneal cavity is not 
clearly outlined a further 1-2 millilitres of opaque medium are 
injected under vision with the image intensifier. If the radio 
opaque material remains localised and the curve of the anterior 
abdominal wall is visualised the catheter is considered to be in the 
foetal peritoneal cavity. In the early cases with this technique 
a further antero-posterior x-ray film was taken after the injection 
of 2-3 millimetres of Hypaque but this is not considered necessary 
now.
PLATE 111
This plate from an early case in the series shows the needle and 
catheter in position with the foetal diaphragm and abdominal wall 
outlined by the Hypaque.
An attempt is made to withdraw some Hypaque from the abdominal 
cavity and then preparation is made to inject the prepared blood.
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According to the maturity and estimated size of the foetus 
40-120 millilitres of warm washed packed cells of Group 0 Rhesus 
negative blood concentrated to a haemoglobin of 20 gms.^ o are 
injected through the catheter using a three-way Tap and a 10 milli­
litre syringe* The blood is held in a giving set,and as the 
catheter is very fine^it has been found to be easier to introduce 
the blood using the relatively narrow bore of a 10 millilitre 
syringe talcing approximately half a minute per millilitre. At 
the end of the procedure the needle and catheter are removed and 
the abdominal wound sealed with collodion and a gauze swab.
The use of the grid and the vertical insertion of the needle 
usually enables the target area to be reached at the first attempt. 
One hazard is that an anteriorly situated placenta may have to be 
traversed but this is a risk of all techniques when a placenta is 
so situated. Provided that only one clean puncture is made 
through the placenta^ there appears to be little risk to mother or 
baby and less risk than multiple punctures at an angle in an attempt 
to avoid the placenta (Liley, I969 - Personal communication).
Radiation dosage is carefully controlled. The average screen­
ing time with the low dosage image intensifier and Television Monitor 
is 1-J minutes and the average number of films per transfusion is two.
OTHER METHODS OF INTRA-UTERINE TRANSFUSION
TRANS-ABDOMINAL AMNIOSCOPY AND TRANSFUSION (WADE. OGDEN, ANDERSON 
AND DAVIS, 1969)
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In two patients Wade and his colleagues used a modified 
paediatric fibre optic cystoscope 4 millimetres in diameter 
to place a needle into the peritoneal cavity of a foetus. The 
procedure was performed under local anaesthesia. The cystoscope 
was inserted through a thin-walled sheath into the amniotic cavity 
and a collapsible latex balloon, previously fitted over the end 
of the cystoscope, was inflated with air thereby pushing aside 
the turbid amniotic fluid. The umbilical cord was located and 
traced to its foetal origin. The Tuohy needle was then directed 
into the lower abdomen of the foetus under direct vision.
OPEN OPERATIVE TECHNIQUE
This has been described by Freda and Adamson (1966); Asensio, 
Figueroa-Longo, Pelegrina (1966) and Seelen, van Kessel and Been 
(1970). In this method the placenta was localised using radio­
active isotopes and the abdomen was opened* A small incision 
was made in the uterus opposite a foetal foot and the membranes 
freed but not incised. The foetal foot surrounded by bulging 
membranes was brought out and the membranes incised. The leg was 
delivered as far as the groin and a purse-string suture put round 
the groin catching membranes and uterus so that as little amniotic 
fluid as possible escaped. The femoral artery was cannulated and 
220 millilitres of fresh Group 0 Rhesus negative blood given by 
exchange transfusion. The limb was replaced in the uterus and 
membranes, uterus and abdomen closed. In the case of Freda and 
Adamson the procedure was well tolerated by both mother and foetus 
but two days later precipitate labour followed and a 27 week baby
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was delivered which died in the neonatal period from atelectasis. 
Asensio and his colleagues reported the procedure with slight 
modifications in particular using the femoral vein. They success­
fully delivered a Porto Rican woman who had no living children of a 
live female child which survived.
A further series of open operative intra-uterine transfusions 
was reported by Seelen et al at the International Rhesus Symposium 
in Milan in October, I969 with depressing results.
A further variation of the open operative technique is described 
by Wade and his colleagues (1969). In their series of three
cases, hysterotomy was performed on patients with foetuses of less 
than 25 weeks* gestation, the foetus was delivered from the uterus 
and a silastic catheter inserted into the abdominal wall of the 
foetus and secured with sutures. The foetus was returned to the 
uterus, the catheter brought through a separate wound in the side of 
the uterus and the first transfusion performed. The membranes 
were then closed and the amniotic fluid replaced with sterile saline. 
In none of the three cases was a living child obtained.
D I S C U S S I O N  O F  P R E S E N T  S E R I E S  O F  
I N T R A - U T E R I N E  T R A N S F U S I O N S
A total of 24 patients were treated involving 26 pregnancies 
with 48 transfusions. Ten babies have survived and are well 
following the procedure, with one exception which will be discussed 
later.
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PHEVIOÜS HISTORY
This is summarised on Table 1.
One patient had three stillbirths, one had three stillbirths 
and one neonatal death, one had two stillbirths, four patients had 
one stillbirth and two had one neonatal death. Ten of the remain­
ing patients had a history of babies requiring exchange transfusion.
Those patients who had a previous stillbirth had an 80-90^ chance of 
losing a child in this pregnancy and of all patients who have had a 
baby requiring exchange transfusion there is a chance of intra­
uterine death (Mollison, 196?). It is difficult to estimate the 
risk of intra-uterine death in the two patients who received intra­
uterine transfusions subsequent to a previous pregnancy with intra­
uterine transfusion but the risk must be very high.
LIQUOR FINDINGS
These are illustrated in Figure 1.
All the liquor results were, at the initial examination, in Zone 3i 
or entered Zone 3» of a Liley type prediction graph after serial exam­
inations. Three cases, 3, l6 and 22, started in Zone 2. On liquor find­
ings alone one might in retrospect criticise the extreme step of intra­
uterine transfusion in some cases. In case 12 only one specimen 
of liquor was examined but was in Zone 3 and the patient had a 
history of a baby requiring multiple exchange transfusions. In
case 3 the liquor optical density started in Zone 2 and only reached
TABLE 1
111,
Case
No.
Parity Genotype of 
husband
Previous S.B. 
or N.N.D.
Previous
exchange
Outcome
1 10 4- 1 cDE/cde 3 S.B.
1 N.N.D.
— S.B.
2 4 + 2 cDE/cDe 2 S.B. - S.B.
3 1 + 1 CDe/CDe — - N.N.D.
4 7 cDE/cDE 1 S.B.
5 1 + 1 CDe/CDe - - A & W
6 2 CDe/CDe — - A 8c W
7 4 CDe/cDE 3 S.B. - A & W
8 3 CDe/CDe - 2 A 8c W
9 1 CDe/cDE — 1 A 8c W
10 2 CDe/cDE - 1 S.B.
11 1 CDe/ode - — N.N.D.
12 2 cDE/cde - 1 A 8c W
13 6 CDe/cDE 1 N.N.D. 1 A & W
14 3 CDe/GDe - 1 I.U.T. A 8c V/
13 3 CDe/CDe - 1
S.B.
16 2 + 2 Not done 1 S.B. — A & W
17 2 cDE/cde - 1 A & W
18 3 cDE/cde 1 S.B. 1 N.N.D.
19 2 cDE/cde 1 S.B. 1
S.B.
20 3 cDE/cde — 1 N.N.D.
21 2 CDe/cde - 1 N.N.D.
22 8 cDE/cDE 1 S.B. 1 exchange 
1 I.U.T.
N.N.D.
23 3 CDe/cDE 1 N.N.D. 1 S.B.
24 3 CDe/cde - — S.B.
23 4 + 2 cDE/cde - — S.B.
26 3 CDe/CDe — 1 N.N.D.
KEY &.B»
A & ¥
Stillbirth 
Alive and well
N.N.D. Neonatal death
I.U.T, - Intra-uterine 
transfusion
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Zone 3 on the last examination but again there was a previous 
history of a child requiring exchange transfusion. In case 
20 the liquor optical density dropped to Zone 2 after intra­
uterine transfusion at 26 weeks but intra-uterine death occurred 
in 3 days. All the other liquor findings were strong indications 
for intra-uterine transfusion.
RESULTS
These are summarised in Tables 1 and 11.
Of the l6 babies which did not survive, 7 were neonatal deaths. 
One died of a cardiac arrest during a second exchange transfusion; 
the others were hydropic at delivery and failed to respond to 
immediate resuscitation and transfusion. The other 9 infants 
lost, died in utero. Autopsy was performed on all but one of 
these but the findings were difficult to interpret because of the 
degree of autolysis. All those examined showed histological 
evidence of severe erythroblastosis foetalis in liver and spleen. 
Examination of cord or heart blood was unfortunately not possible 
due to haemolysis. In none of these cases was there obvious 
trauma from the intra-uterine transfusion. The time interval 
between the last intra-uterine transfusion and intra-uterine death 
was a minimum of three days and a maximum of nine days - a 
significantly short interval. One patient had a placenta praevia 
and had antepartum haemorrhages which no doubt did contribute to 
the unfortunate outcome. One patient had a massive accidental 
haemorrhage three days after intra-uterine transfusion and delivered
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a stillborn foetus. It is interesting to note that she had an 
equally massive accidental haemorrhage with a stillborn foetus in 
a previous pregnancy without intra-uterine transfusion. Another 
patient also had an accidental haemorrhage.
This total of 9 intra-uterine deaths from 48 transfusions 
gives a maximum risk of l8.% with each transfusion if all deaths 
are caused by the transfusion. Such a risk is high especially if 
the risk is cumulative when 2 or 3 transfusions are necessary but 
without intra-uterine transfusion all those babies would probably 
have died. However, there was no definite evidence that these 
deaths were a result of the intra-uterine transfusion.
The 10 surviving babies required either exchange transfusion 
or simple top-up transfusion. The mean cord blood findings were - 
Haemoglobin 10.1 gm.^ and serum bilirubin 6 mgra.^ . The amount of 
adult blood in the cord blood varied from 3(% to 100^ using the 
mixed agglutination technique and the acid elution technique. In 
cases l4 and l6 the percentage of adult blood in the cord was 100^.
In both these cases no exchange transfusion was necessary - only 
simple top-up transfusions - as the following detailed descriptions 
show.
CASE 14
This baby was reported as being Group 0 Rhesus negative with a 
cord haemoglobin of 12.4 gm.^ o and serum bilirubin of 3.1 mgm.%.
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The direct Coomb's test was negative. All the cells appeared to 
be of the adult type. Anti D was detectable by both saline and 
albumen techniques. Date of birth was 15.5.67. Anti D remained 
detectable by the enzyme technique until 14.8.6?. the titre at 
birth being 1/64 and the Coomb's test remained negative until
13.7.67 when about 25^ of the cells were Coomb's positive. During 
this period the haemoglobin fell slowly to 8 gm.% and the infant 
was given two top-up transfusions. The serum bilirubin never rose 
above 13 mgm.%*
CASE 16
A similar picture was found in this baby. At delivery on
29.7.67 the cord blood was grouped as 0 Rhesus negative with a 
haemoglobin of 13*6 gm.^ and a serum bilirubin of 3.4 mgm.% and 
all the cells appeared to be of the adult type with a negative 
direct Coomb's test. Anti D was present in the baby's blood to 
a titre of 1/8 by enzyme technique. The bilirubin never rose above 
8.2 mgm.% although the haemoglobin dropped slowly over eight weeks 
necessitating two top-up transfusions. On 26.9.6? the direct 
Coomb's test was again negative but a positive result was obtained 
by using the Jones and Silver technique (1938). Anti D remained 
present in the infant's blood in minute quantities until the same 
time.
Both cases illustrated the potential of great success with 
intra-uterine transfusion. Each had a very high percentage of 
donor cells present at birth and the need for exchange transfusion 
was avoided. While it is realised that many factors play a part in
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the production of the blood picture in these infants it can be 
seen that the transfused adult celle seem to have a life of 2-3 
months. What part the donor blood, given by intra-uterine 
transfusion, plays in the suppression of the child's own marrow 
and what part the anti D antibody plays in haeraolysing the few 
red cells produced by the baby in the first few weeks of life 
remain matters for conjecture.
RELATION OF INTRA-ÜTERIMI TRANSFUSION TO MATURITY
This is summarised in Table 111.
Neonatal mortality in infants with Haemolytic Disease induced 
at 32 weeks' gestation can be or higher compared with 20^ 
mortality for those induced at 35 weeks (Robertson, 1964 and Walker 
et al, 1957). Intra-uterine transfusion based on liquor examinations 
in the mid-trimester of pregnancy and previous history, would seem to 
remove the need for such early induction. It is, however, true that 
early intra-uterine transfusion e.g. at 24 weeks or earlier, is 
technically more difficult than those performed at 30 weeks' gestation 
or later. In addition such an early start means that 2, 3 or 4 
transfusions are necessary to prolong gestation until the baby is 
mature enough to have a good chance of survival. This, of course, 
means exposing the baby to the cumulative risks of intra-uterine 
transfusion. Thus it is not surprising that the overall salvage 
rate at 26 weeks or earlier is only ZCf/o (Queenan, I969).
In the present series 12 of the 26 babies were transfused
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TABLE 111
Transfusion related Maturity
Time of initial transfusion in weeks
26-27 27-28 28-29 29-30 30-31 31-32 32-33
All cases 5 1 3 5 3 3 4
Survivors 2 - - 2 2 2 2
This table shows the maturity of the foetus at the time of the initial 
transfusion.
TABLE IV
Treatment of Survivors
Cases
No. of Exchange Transfusions Top-up alone
1 2 3
10 1 4 3 2
This table shows the number of exchange transfusions and top-up 
transfusions in the surviving infants.
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before 30 weeks with a survival rate of 33^ #^ The latest
initial transfusion was at 32g weeks and of those later trans­
fusions 42.% survived. The later the initial transfusion can 
be carried out the better the chance of survival due to the 
lesser risk of the procedure and the lesser degree of affection 
of the baby. In very late transfusions i.e. at 35 weeks or 
more, the doubt is raised whether in fact intra-uterine trans­
fusion is really necessary or whether it would be safer than 
immediate delivery. With improved technique and further 
experience early transfusions should produce better results. In 
the present series there is an overall survival rate of 38*5% 
which is comparable with most international series (Queenan, I968; 
Karnicki, 1969; Friesen et al, I967; Fairweather et al, I967;
Wade et al, I969 and Liley, 1970).
PRESENCE OF HYDR0P8 FOETALIS IN RELATION TO THE USE OF INTRA-UTERINE 
TRANSFUSION
There was much discussion at the Rhesus Symposium in Milan 
(1969) about the cause of hydrops foetalis and the effect of intra­
uterine transfusion on such a baby. It was agreed that when the 
full hydropic syndrome had not developed and only ascites was present 
then intra-uterine transfusion could be of benefit. In the present 
series this was found to be true. In cases I6 and l4 ascitic fluid 
was withdrawn at the first transfusion and both babies survived. In 
case 3 ascitic fluid was also withdrawn but oedema of the foetus 
became apparent on both x-ray films and the baby was hydropic at 
delivery and lived only 48 hours. In none of the other cases 
was ascites or hydrops demonstrated at the time of intra-uterine 
transfusion. This experience supports other workers who feel that
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once the full hydrops syndrome has developed whatever the cause - 
profound anaemia or liver failure, the outlook even with intra­
uterine transfusion is hopeless. Indeed, in view of the 
maternal risks it is doubtful whether it is justifiable even to 
attempt intra-uterine transfusion on a clinical hydrops when the 
results are so discouraging. When, however, only ascites is 
present intra-uterine transfusion can be a worthwhile measure.
CAUSES OF FOETAL AND NEONATAL LOSS 
This is summarised in Table -V..
Total number of stillbirths was 9* One of these was 
unconfirmed as erythroblastosis due to autolysis of the foetus 
making histological examination difficult. Of the others one 
was associated with a placenta praevia and antepartum haemorrhage. 
Two others were associated with mixed accidental haemorrhages. All 
of these babies showed histological evidence of erythroblastosis 
foetalis.
Of the neonatal deaths, one had a cardiac arrest during a 
second exchange transfusion, a recognisable risk of exchange trans­
fusion and in no way attributable to intra-uterine transfusion, and 
one was delivered at 29 weeks by elective Caesarean Section because 
of maternal eclampsia. This was a very premature baby showing 
signs of erythroblastosis which survived for only a few hours. The 
others were all hydropic and failed to respond to resuscitative 
measures and exchange transfusion.
121,
TABLE V 
PERINATAL MORTALITY 
Cause of Neonatal Deaths
Hydrops foetalis alone 4
Hydrops foetalis + Maternal eclampsia 1
Hydrops foetalis + Respiratory Distress Syndrome 1
Cardiac Arrest during exchange transfusion 1
TOTAL
Cause of Stillbirths
Hydrops foetalis alone 5
Erythroblastosis + Placenta Praevia 1
Erythroblastosis + Mixed Accidental Haemorrhage 2
Unexplained intra-uterine death 1
TOTAL
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FATE OF SURVIVORS
With one exception all the survivors are normal children in 
every way, having passed the milestone of development at times 
comparable to children who have not had their unusual foetal and 
neonatal background*
The child who has not progressed normally v/as delivered by 
Caesarean Section at 35 weeks having had one intra-uterine trans­
fusion* She was in good condition at birth with a cord bilirubin 
of 6.2 mgm.% and a haemoglobin of 10.2 gm.^. Exchange trans­
fusion was carried out one hour after delivery and repeated 24 hours 
later because of hyperbilirubinaemia. During the second exchange 
transfusion she had a cardiac arrest but responded to prompt and 
intensive resuscitation. A further exchange was carried out on 
the third day and progress seemed normal in the neonatal period.
When re-assessed at six months she was noted to be developing slowly^ 
and subsequent examination confirmed the diagnosis of spasticity.
She is now attending a day centre for handicapped children and is 
making slow but sure progress although obviously mentally handi­
capped as well. Whether the cause was kernicterus or the result 
of the severe anoxic episode is uncertain.
METHOD OF DELIVERY
Of the 26 cases in the present series, l8 were delivered by 
Caesarean Section and 9 of these babies survived; there were 6 
neonatal deaths and 3 stillbirths. Eight babies were spontaneous
123,
vertex deliveries and of these one is alive and well. There 
was one neonatal death and there were 6 stillbirths.
Initially the policy of delivery was one of planned Caesarean 
Section except for those cases in which there was an intra-uterine 
death, when labour was induced and a spontaneous delivery followed.
The one survivor which was born by vaginal delivery followed 
spontaneous premature rupture of the membranes. In recent cases, 
not in this series, a policy of induction with a fixed induction- 
delivery interval is being followed. This is an attempt to reduce 
the risks of Respiratory Distress Syndrome to which the premature 
baby delivered by Caesarean Section is particularly prone. Respiratory 
Distress Syndrome, proved a lethal complication in only one of the 
present cases but it was a minor complication in 3 other cases.
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G E N E R A L  D I S C U S S I O N  OF I H T R A - Ü T E E I N E
T R A N S F U S I O N
Where severe Haemolytic Disease of the Newborn is suspected 
from a previous history and amniocentesis findings, intra-uterine 
transfusion would seem to have a definite use in enabling the 
obstetrician to delay delivery until the foetus is of a maturity 
which has a good chance of survival. Neonatal mortality for 
premature babies unaffected by Haemolytic Disease of 32 weeks* 
gestation is of the order of 4 %  (Crosse, 1957). This must 
inevitably be increased when Haemolytic Disease is of such severity 
as to warrant delivery as early as 32 weeks. It is in this early 
group of affected foetuses that intra-uterine transfusion can play 
a vital part in the management. Stillbirth or neonatal death 
occurring at a later maturity - at 35-37 weeks - can be prevent­
ed if the warning signs are recognised and induction carried out. 
With prompt and adequate treatment these infants have a good chance 
of survival.
It is well to remember before looking too critically at the 
survival rate of any series of intra-uterine transfusions that the 
women concerned were subject to all the hazards of pregnancy which 
can occur without the complication of intra-uterine transfusion. 
Indeed it is said that accidental haemorrhage and hypertension are 
common in the sensitized woman (Zilliacus and Eriksson, 1958).
The babies too are liable to the hazards of labour and the 
neonatal period. Respiratory Distress Syndrome of the newborn is
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a not uncommon complication of the apparently healthy premature 
infant and even exchange transfusion itself carries a mortality 
of (Phibbs, I966).
The maternal attitude to intra-uterine transfusion must also 
be taken into account before embarking on a planned programme of 
transfusion. Most women, particularly if they have lost one or 
more babies, are enthusiastic about any procedure which offers a 
hope of a live child and will willingly agree to undergo intra­
uterine transfusion. Occasionally, however, a woman has not 
the mental attitude to withstand the uncomfortable and perhaps, to 
the lay mind, alarming operation,and the clinician must think care­
fully before embarking on a programme which carries a slight but 
definite maternal risk. Whatever the patient's decision, and 
it is hers finally, she can only be given the hope and not a promise 
of a live child.
The decision as to the type of intra-uterine transfusion to be 
employed in the present time is simple. All types, apart from 
the closed technique originally described by Liley (I965) and used 
with slight modifications by others, carry such a high foetal 
mortality and risk to the mother that they remain largely experimental.
It is in the group of patients with a previous history of 
stillbirth and neonatal death that successful intra-uterine transfusion 
carries most satisfaction to mother and clinician but it is the group 
in which success is hardest to achieve.
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When amniocentesis is carried out earlier than the routine 
29 and 31 weeks of pregnancy this is usually done at 24-25 weeks 
and if deemed necessary a programme of planned transfusion begun 
shortly afterwards. Apart from the history, antibody titre 
and zygosity of the husband the deciding factor is the optical 
density deviations of liquor at 450n lying in the upper zone of 
a Liley type graph (Liley, I96I). Transfusions are begun at 
26 weeks or earlier and the difficulty in technique at this stage 
may be severe. The foetus is extremely mobile and the target 
area extremely small at this early stage. Three or more trans­
fusions are necessary before delivery to ensure the foetus is 
delivered in the best possible condition. The survival rate
at 26 weeks or under, however, is only 2 %  (Queenan, 1969).
In the later group of candidates for intra-uterine transfusion, 
when there is no history of badly affected pregnancies, the 
decision for active intervention must be taken on routine 
amniocentesis results beginning at 29 weeks. This means that 
intra-uterine transfusion begins about JO weeks and only one or 
at the most two are needed for the foetus to reach a maturity with 
reasonable chance of survival.
Technically intra-uterine transfusion at this stage of 
pregnancy is a much easier procedure and the foetuses are less 
affected making the success rate for this group greater. With 
initial transfusion at 28 weeks or later Queenan (I969) reports a 
salvage rate of 5%.
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It is clear, therefore, that the later the intra-uterine 
transfusion is carried out the better the results. From 25 
weeks onwards the results improve and reach a maximum at 30-32 
weeks. The survival rate with initial transfusion at 19-24
weeks is so poor that it is questionable whether it should be 
attempted. Transfusion initiated at 35 weeks produces good 
results but in view of the risk involved it again is questionable 
whether it should be done. Close observation of the foetus at 
this stage and prompt delivery should ensure an equally good 
survival rate.
In either group it can be difficult to judge the efficacy 
of intra-uterine transfusion if the foetus at delivery is judged 
to foe less severely affected than predicted. Strict standard,, 
of amniotic fluid values is essential in the decision to transfuse 
or not. A strict standard may occasionally result in an intra­
uterine death but this is preferable to performing intra-uterine 
transfusions on foetuses which would have survived without it 
and thus incurring the not insignificant risk of the procedure 
itself.
Liley indicated in his very early reports on intra-uterine 
transfusion that the presence of foetal ascites or hydrops would 
prevent the absorption of blood from the peritoneal cavity. This 
has later been shown not to be so - at least in the presence of 
ascites alone (Queenan, 1968) so that the presence of ascites alone 
does not debar a foetus from a successful transfusion. The presence
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of hydrops, however, does not produce such a clearcut picture.
Cases of gross hydrops as defined by foetal oedema shown by 
amniogram, ascites and a severe aniniotic fluid deviation at 450n 
show poor results and success or failure depends on the degree of 
hydrops before treatment (Lucey, I969).
As a severe degree of hydrops is usually accompanied by a 
large placenta the dangers of transfusion are increased and the 
results may not warrant the risks to the mother.
The object of antenatal care and management is to produce a 
child which is at least responsive to paediatric care and although 
the operation of intra-uterine transfusion cannot guarantee this, 
it succeeds in a percentage of cases where, without it, the outcome 
would be 10% mortality. Although the percentage success may not 
be as high as one would like intra-uterine transfusion offers hope 
and some success to the woman whose reproductive capacity is 
compromised by Rhesus isoimmunization.
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I S O I M M U N I S A T I O N
In the years which followed the discovery of the Rhesus 
factor and the full realisation of its effects, thoughts of many 
workers turned to the possibility of prevention. Initially 
"prevention" was simply an attempt to ameliorate the effect on 
the foetus.
One of the first substances used to improve the outlook for 
the foetus was the Rhesus Hapten. This was introduced by 
Carter in 194? as an ethereal extract prepared from red cell stroma 
and in 1949 she first called this material Rhesus Hapten. A 
Hapten is a substance which, when combined with a suitable carrier 
such as protein, can stimulate antibody production in a host and 
can also react specifically with that antibody, but which without 
a carrier cannot by itself produce antibodies. Carter's rationale 
in the use of the Rhesus Hapten was to neutralise the existing 
antibody in a patient without stimulating the production of more 
antibody. The preparation called Rhesus Hapten was initially 
crude but Carter, Williamson, Loughrey and Ingram (1936) reported 
the successful treatment of 133 patients. The Hapten was given 
by intramuscular injection in large amounts. Later, Carter and 
Lewis (1938) described the successful treatment of I7 sensitised 
patients with orally administered Hapten. In 1939 Carter 
published a review of her work on the Rhesus Hapten and claimed 
that, if Rhesus Hapten was given to a Rhesus negative woman at any 
time after discovery of initial sensitisation and if she had no 
history of erythroblastotic infants, the success rate was 98^ .
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She further claimed that if a previously sensitized woman with 
a homozygous Rhesus positive husband and a history of foetal 
loss from Haemolytic Disease were given the Hapten before a new 
pregnancy began success would be 10%. Carter claimed that 
the use of Rhesus Hapten both between and during pregnancies 
gave the best results.
In view of the availability of the raw material for the 
production of Rhesus Hapten - time expired Rhesus positive red 
cells of any ABO group, from which the proteins are precipitated 
with alcohol and then the liquid Hapten extracted from the 
precipitate with Dichloromethane or ether - it is surprising 
that this form of protective treatment did not become widespread.
No other workers reported its use and one is forced to conclude 
that her claims cannot be substantiated.
Another type of protective therapy which gave moderate 
encouragement for some time was the use of corticosteroids.
These were used in the hope that they might work in one of three 
ways :-
(1) To suppress the production of maternal antibody.
(2) To prevent sensitisation of the foetal cells by maternal antibody.
(3) To lessen the severity and rapidity of destruction of sensitized
foetal cells.
Opinion on the value of corticosteroids varied. Hunter (1934)
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claimed that corticosteroids had a definite value but De Costa, 
Gerbie and Potter (1934) disagreed and found little to recommend 
the administration of cortisone to Rhesus negative sensitized 
patients* Wiener (1934) also took strong exception to Hunter's 
views and made the very valid point that the pattern of Haemolytic 
Disease varies a great deal in sensitized women. It is accepted 
that even if a woman loses a baby from the effects of Haemolytic 
Disease she may have a less affected or unaffected baby in the 
following pregnancy. Thus an unaffected baby may be explained 
on the zygosity of the husband if he should be heterozygous, but 
on many other occasions the explanation of a less severely affected 
baby is unknown.
It is difficult, therefore, to evaluate properly the use of 
such substances as corticosteroids in Haemolytic Disease when there 
are so many unmeasurable factors present and when the use of a 
substance such as corticosteroid is not without danger in itself. 
Corticosteroids are no longer used in the sensitized patient.
Another attempt at inhibition of Rhesus antibodies to try to 
protect the foetus v/as made by Pearse and Hobel (1964). As 
ribonucleic acid derivatives were thought to be similar to the 
terminal chemical group of the erythrocyte antigen structures and 
could inhibit saline anti D but not albumen anti D and as it is 
known that glucosamine and galactosamine are components of the 
polysaccharide blood group antigens they decided to try out the 
effects of glucosamine. They report only one case where a
sensitized woman was given 10 percent glucosamine 900ml. at 27 weeks.
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The effect on antibody level was minimal and the patient was 
delivered of a stillborn foetus at 31 weeks.
The use of phenobarbitone to reduce the risk of kernicterus 
in the neonate was suggested by Maurer, Wolff, Finster, Poppers, 
Pantuck, Kuntzraan, Cunney (I968) and later by Trolle (I968).
This is given to the mother in the last few days of her pregnancy 
and later to the baby. The rationale is that hepatic enzyme 
activity is enhanced and there is an increase in Glucuronyl 
transferase which is necessary for the biosynthesis of bilirubin 
glucuronamide.
One of the most recent attempts to take positive action 
during pregnancy to minimise the effect of Rhesus antibodies on 
the foetus of a Rhesus sensitized patient has been by the use of 
intensive plasmapheresis with a view to reducing the amount of 
circulating antibody. Plasmapheresis is a process whereby one 
or two units of blood are removed from a patient by venesection, 
the plasma separated and the red cells returned to the patient.
This can be done frequently and large quantities of plasma removed. 
It has the added benefit that large quantities of plasma containing 
high titres of anti Rhesus (D) can be made available for the 
preparation of anti Rhesus (D) immunoglobulin. This latter 
aspect of plasmapheresis will be discussed in detail later.
Powell (1968) used plasmapheresis on a series of eight 
sensitized women with a poor Rhesus obstetric history. He used 
it on the basis that a woman with a low antibody titre rarely 
produces a badly affected baby and attempted to lower the antibody
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titre in his patients by removing 2,000 ml. of whole blood daily 
over a period of 7-12 days. He found, however, that the anti­
body titres dropped to a limited degree but rose again in 2-6 
weeks as did the serum proteins. Powell used adjuvant measures 
of therapy such as intra-uterine transfusion as well in selected 
cases so that it is difficult to judge the effect of plasma­
pheresis per se. Perhaps the most valuable information obtained 
from his series was that intensive plasmapheresis in pregnancy did 
not harm the patients.
This work was repeated by Clarke, Elson, Bradley, Donohoe, 
Lehane and Hughes-Jones (1970)• They showed that intensive 
plasmapheresis lowered the concentration of plasma proteins, 
including total IGg, and individual antibodies. They estimated 
the fall in antibody concentration by a method using radio-active 
anti D gamma globulin and not by the conventional agglutination 
technique. In general they found that the antibody content 
mirrored the IGg. level during plasmapheresis.
The eight patients in the series were treated by conventional 
methods including intra-uterine transfusion so once again it is 
difficult to estimate the effect of plasmapheresis alone.
It must be emphasised again that most of the measures described 
are primarily attempts to decrease the effect on the foetus and do 
not attain real prevention of iso-immunization of the mother.
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When the circumstances in which isoimmunisation occurs were 
realised - these being (1) Repeated blood transfusions (2) 
Therapeutic intramuscular injections of blood (3) Experimental 
injection of blood into volunteers (4) Foeto-maternal haemorrhage 
during pregnancy - thoughts turned to the significance of these 
factors in relation to maternal isoimmunisâtion. The obvious 
primary step of matching Rhesus negative blood for Rhesus negative 
girls and women before the age of the menopause was taken and 
therapeutic intramuscular injections of blood to women and chil­
dren were stopped.
In spite of these measures and the additional attempts to 
ameliorate the effect of Haemolytic Disease the mortality and 
morbidity kept complacency at bay and reminded workers that there 
was need for a more fundamental approach to the basic problem - 
the prevention of isoimmunisation.
Two important observations had been made before I96O, namely:-
(1) TRANSPLACENTAL HAEMORRHAGE
This is the term used to describe the leak of foetal red blood 
cells from the placental villi into the maternal circulation.
The potential leak is thought to occur most often at delivery. 
Transplacental haemorrhage will be discussed in detail in the 
following pages.
(2) THE ABO PROTECTIVE FACTOR
This is the term used to describe the prevention of isoimmunisâtion
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by the rapid destruction of foetal cells in the maternal
circulation when they are of an incompatible ABO group.
This, too, will be discussed in detail later.
The second observation will be discussed first as most of 
the detailed work on this was done at an earlier stage though 
it is dependent on the first observation.
THE ABO PROTECTIVE FACTOR
Levine (1943) noted that among families with children 
affected by Haemolytic Disease of the newborn due to anti Rh. (D) 
there was a deficiency of matings in which the husband was ABO 
incompatible with his wife. This observation has been confirmed 
by other workers - Nevalinna and Vainio (1956); Levine (1958); 
Murray, Knox and Walker (1965) and supported by experimental work 
by Stern, Davidson and Masaitis (1956).
Levine, Durham, Katzin and Vogel (1941) and Levine, Katzin 
and Durham (194l) originally postulated that for the immunisation 
of the mother there must be an escape of foetal red blood cells 
into the maternal circulation. With modern methods of detecting 
these foetal cells in maternal circulation several workers studied 
the effect of the ABO protective factor. Cohen and Zuelzer (I967) 
found a lower incidence of foetal cells in the maternal circulation 
when the foetus was ABO incompatible with the mother. In similar 
studies, Finn, Clarke, Donohoe, McConnell, Shepperd, Lehane and 
Kulke (1961) found no foetal cells in ABO incompatible pregnancies 
but Fraser and Raper (I962) found foetal cells in I6 out of 100 
postpartum ABO compatible pregnancies. Various reasons have been
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suggested for this phenomenon - rapid removal of the incompatible 
cells before the Rh. antigen can effect stimulation (Race and 
Sanger, 1950), competition for the different antigens of the ABO 
and the Rhesus blood group systems by the same clones of cells 
(stern, Goodman and Berger, I96I) or the sequestration of the ABO 
incompatible cells at a site unfavourable for anti D production 
(Mollison, 1967a).
ABO protection is not complete. It has been estimated by 
Nevalinna and Vainio (1956) that in about 20^ of such ABO 
incompatible pregnancies immunization occurs. In more recent 
studies Murray, Knox and Walker (I965) estimated that maternal 
anti A gives about 90$ protection while maternal anti B gives only 
about 55$ protection. Ascari, Levine and Pollack (I969) suggested 
that protection from ABO incompatibility appears to be more likely
to fail if the mother is of an ABO group other than group 0. This
may, however, be partly a reflection of ABO group frequencies.
An additional factor may be that women who are group A or B
tend to form the saline agglutinating or IgM anti A or anti B
while women who are group 0 form some albumen agglutinating or IgG 
anti A and anti B fairly frequently (Rawson and Abelson, I960),
The two immunoglobulin types may render foetal erythrocytes 
iramunologically inert at different times.
Group B foetal cells appear to behave in an unusual way.
Murray et al (I965) state that the ABO protection factor is reduced 
when the foetal blood group is B but indicated that babies which
i4o.
were group B tended to be relatively mildly affected by Haeraolytic 
Disease. Further evidence of unusual behavior of group B was 
given by Cohen and Zuelzer (I967). They describe two instances 
in which group B foetal cells persisted in the maternal circulation 
for several weeks after massive transplacental haemorrhages, 
although the foetal cells were ABO incompatible with the mothers 
and were partially coated with maternal anti B.
Once immunization to the Rhesus factor has taken place, the 
effect of ABO incompatibility is not clear but several observations 
have been made. Nevalinna and Vainio (1956) state that after 
immunization has talcen place the ABO factor is no longer protective 
while Murray et al (I965) found that after immunization Rh. positive 
infants were less severely affected if the foetus was ABO 
incompatible with the mother. Vos (I966) found that maternal anti" 
Rh. (D) titres tended to be lower in these cases where the 
immunizing pregnancy was ABO incompatible.
The other major observation made before I96O was that of 
Transplacental Haemorrhage.
TRANSPLACENTAL HAEMORRHAGE
Two studies by Levine, Durham, Katzin and Vogel (19^1) and 
Levine, Katzin and Burham (I94l) suggested that foetal red cells 
could cross the placenta during pregnancy and induce immunization 
in the mother. A case of severe neonatal anaemia was described 
by Wiener (1948) who postulated the cause as a massive haemorrhage
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from foetus to the mother. Chown (1954) demonstrated the 
presence of foetal cells in maternal circulation using a 
differential agglutination technique. This method, however,
is not sensitive enough to detect small numbers of foetal cells 
and it was not until 1957 when Kleihauer, Braun and Betke 
described the acid elution technique that the study of foetal 
cells in maternal circulation became detailed. The test is 
described in English by Zipursky, Hull, White and Israels (1959) 
and is dependant on the differential elution of adult and foetal 
haemoglobin by a citric acid/disodium hydrogen sulphate buffer 
at a pH of 3*3 approximately. While this test is now widely 
used it is not entirely satisfactory. It is easily upset by
poor blood films, minor changes in pH, temperature, and staining 
techniques. It also requires considerable technical skill for 
interpretation. In addition it is known that foetal haemoglobin 
does occur in adults in certain haematological disorders and in 
such cases foetal type cells can be demonstrated in the circulation 
by the acid elution technique (Zipursky, Neelands, Pollock, Chown, 
Israels, I96I). Foetal type cells were also found by Cohen,
Zuelzer, Gustafson and Evans (1964) in 5 of l45 non-pregnant blood 
donors using the acid elution technique.
The other methods of estimating the presence of foetal cells, 
while perhaps more accurate, are difficult and time-consuming e.g. 
mixed agglutination technique (Jones and Silver, 1956) and 
immunofluorescence (Cohen and Zuelzer, 1964).
Many workers confirmed the original theory of Levine of trans-
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placental haemorrhage and its influence on immunization (Finn, 
Clarke, Donohoe, McConnell, Shepperd, Lehane and Kulke, I96I; 
Taylor and Kullman, I96I; Fraser and Paper, 1962; Zipursky 
et al, 1963? Finn, Harper, Stallings and Krevans, I963) and 
work to investigate the timing of transplacental haemorrhage in 
relation to immunization plus the effect of obstetric techniques 
in relation to transplacental haemorrhage now commenced.
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SIGNIFICANCE OF FOETAL ERYTHROCYTE IN MATERNAL BLOOD
Although foetal cells were found by many workers (Finn et al,
1961; Taylor and Kullman, I96I; Fraser and Raper, 1962;
Zipursky, Neelands, Pollock, Chown and Israels, I963) a little 
doubt still remained as to their significance on a test based on 
elution of adult haemoglobin. It was known that foetal 
haemoglobin occurred in adults in certain haematological disorders 
and in such cases foetal type cells could be demonstrated in the 
circulation by the acid elution technique (Zipursky, Neelands,
Pollock, Chown, Israels, I96I). This test is dependent on the 
alkali resistant nature of foetal haemoglobin (Haemoglobin F).
Rucknagel and Chernoff (1955) measured the level of alkali 
resistant haemoglobin in pregnant women by immunological methods 
and found a rise in haemoglobin F was maternal. Bromberg, Salzberger 
and Abrahamov (1957) found high levels of foetal type haemoglobin in 
patients with a hydatidiform mole. They too, suggested that the 
foetal haemoglobin was maternal in origin.
Experimental support to the theory that the foetal type cells in 
maternal circulation were of foetal origin was given by Zipursky, 
Neelands, Pollock, Chown, Israels (I962) who showed that foetal cells 
injected into volunteers appeared identical to those seen in mothers. 
They found further that these cells, after injection, could be 
identified in the expected concentration and recognised for as long 
as 110 days. Similar findings were reported by Finn, Harper, 
Stallings, Krevans (I963). Borst-Eilers (I96O) further reported 
that the foetal type cells demonstrable by the acid elution technique 
have the blood group antigens of the foetus and not of the mother.
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TIME OF TRANSPLACENTAL HAEMORimAGE
Everyone who has examined the blood of pregnant women looking 
for foetal cells has found them to be present in a proportion of the 
women (Chown, 1968). It has been shown that transplacental 
haemorrhage may occur during pregnancy and also during delivery 
(Taylor and Kullman, 196I; Fraser and Raper, I962; Zipursky et 
al, 1963; Kreiger, I966).
It is thought that small transplacental haemorrhages occurring 
during pregnancy in the unsensitized women may produce a stage of 
priming or sensibilization, the effect of which, is that if there 
is a further transplacental haemorrhage in a following pregnancy, 
the woman will show the full effect of immunisation - that is 
antibodies will be found in her blood and the baby affected to some 
degree with Haemolytic Disease. That such a state may occur, 
with small frequent bleeds producing detectable immunisation and an 
affected foetus in a first pregnancy has been shown to occur with 
varying frequency - 2$ according to Chown (I968) and 6.5$ according 
to Godel, Buchanan, Jarosch and McHugh (I968).
The most usual method of immunisation is that following a larger 
transplacental haemorrhage and this is commonest during delivery 
(Woodrow, Clarke, Donohoe, Finn, McConnell, Sheppard, Lehane, Russell, 
Kulke, Durkin, 1963 and Woodrow and Finn, I966).
TRANSPLACENTAL HAEMORRHAGE IN RELATION TO OBSTETRIC MANOEUVRES
Pregnancy and labour are regarded as normal physiological 
conditions, but certain procedures may be necessary which produce
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an element of disruption of foetal vessels leading to an escape 
of foetal blood into the maternal circulation. Zipursky et 
al (1963) indicated that Caesarean Section, manual removal of the 
placenta and amniocentesis lead to an increased risk of foetal 
blood leak. Taylor and Kullman (I96I) shov/ed an increased 
incidence of transplacental haemorrhage following delivery by 
forceps and Fraser and Raper (I962) showed an increase in the 
incidence of foetal cells in the maternal circulation following 
antepartum haemorrhage.
External cephalic version has also been incriminated in 
increasing foetal maternal haemorrhage (Vos, I967 and Pollock,
1968).
To these should be added the risk of transplacental haemorrhage 
following abortion. Significant amounts of foetal cells have 
been found in the maternal circulation following therapeutic 
abortion using various methods of termination (Walsh and Lewis,
1970 and Parmley, Montague and Miller, 1970). The risk is said 
to be less in threatened or incomplete abortions where there is 
less trauma (Katz, 1969). The early abortion, before 12-l6 weeks, 
is also said to carry a very small risk (Voigt and Britt, I969)*
This will be discussed later in relation to the question of the 
use of anti Rh. (D) gamma globulin.
The relationship of transplacental haemorrhage to immunisation 
was shown by Finn, Clarke, Donohoe, McConnell, Sheppard, Lehane, 
Kulke, (1961) who demonstrated that in women with a ’’large'* trans­
placental bleed there was a significant association with antibody
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formation. They used the Kleihauer technique to assess foetal 
type cells in maternal circulation. They established the 
sensitivity of the technique by comparing two blood smears from 
each of 50 men with an equal number of blood smears from post­
partum women. Each smear was scanned twice for three minutes 
and the number of refractile cells counted. Each individual 
was given a quantitative figure (foetal score) by taking the 
average of the number of refractile cells counted in four scores.
No male score was found to exceed 0.5* To give a wide margin they 
accepted a figure of two or more as indicating a definite trans­
placental haemorrhage.
In the application of the technique to the series of postpartum 
specimens in the I96I series of Finn et al of Rhesus negative women, 
only one smear was made and the foetal score was the average of tv/o 
three-minute screens.
In order to establish a correlation between foetal scores and 
quantity of foetal blood in the maternal circulation mixtures of 
adult and foetal blood were made at varying dilutions. Thus at 
1 in 5,000 the score was 5 (8.D. 1.5)* On the assumption of a
maternal blood volume of about 5 litres a score of 5 would, there­
fore, represent about 1 ml. of foetal blood in the maternal circulation,
Clarke (I967) later indicated that the foetal cell score was 
the number of foetal cells found in 50 low-power fields and roughly 
assessed that a score of 1-4 implied less than 0.25 ml. of foetal 
blood in the maternal circulation. He indicated that a score of 
5"60 meant approximately 0.25-3 ml. of foetal blood and a score of 
over 60 meant more than 3 ml. of foetal blood. Clarke indicated
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that over 0,25 ml, of foetal blood was significant. The significant 
score tkaen as 5 or more foetal cells per 50 low-power fields. A 
small bleed is regarded as 1-4 foetal cells per 50 low-power fields.
A more accurate method of scoring is to relate the number of foetal 
to the number of adult cells and this is the method used in the series 
presented in the later part of this chapter.
The difficulties of the Kleihauer technique have already been 
mentioned (Page l4l ) but in the hands of the Liverpool workers the 
technique appears to give good results and their use of it in 
investigating transplacental haemorrhage and its relation to 
immunization began the modern era of prevention of Rhesus Haemolytic 
Disease.
EXPERIMENTAL WORK IN PREVENTION OF RH. (P) IMMUNIZATION
Finn et al (I96I) injected Cr-51 tagged Rh. positive cells 
into Rh. negative male volunteers and in half the number of volunteers, 
followed this with an injection of 10 ml. serum containing anti Rh. (D). 
They showed that the anti Rh. (D) coated a good proportion of the Rh. 
positive cells and caused the elimination of at least of the tagged 
Rh. positive cells in two days.
Clarke, Donohoe, McConnell, Woodrow, Finn, Krevans, Kulke, Lehane 
and Sheppard (I963) carried out further similar experiments with Rh. 
negative male volunteers, injecting them with Rh. positive cells and 
following this with an injection of serum containing anti Rh. (D) 
antibody. This was a saline agglutinating or complete antibody and 
they found that, compared with control subjects, antibody formation was 
enhanced rather than prevented when saline (complete) anti Rh. (D) was
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used after the injection of ABO compatible Rh. positive blood into 
the volunteers. They also noted that in some cases the injected 
cells survived in the circulation for over a week although, at that 
time, free saline (complete) anti Rh. (d ) could be detected in the 
recipient's serum.
When Clarke et al (1963) used 33-50 ml. of plasma containing 
predominantly albumen (incomplete) antibody they found that only 3 
out of 21 treated men (l4.^o) developed immune antibodies after three 
to four stimuli compared with 11 out of 21 "control" men (32.4$).
The results of this study suggested that a high percentage of 
the injected cells had to be cleared from the circulation within 24 
hours if immune antibody production was to be prevented. In addition, 
Clarke et al (I963) postulated tliat no complete antibody should be 
present and as high a titre of incomplete anti Rh. (D) as possible 
should be given and that the antibody should be present in excess.
INTRODUCTION OF ANTI RH. (D) GAMMA GLOBULIN11
Throughout all these experimental studies the workers were aware 
of the danger of the injection of whole blood and plasma - namely that 
of the transmission of homologous serum hepatitis to the volunteers.
The donor of the blood in all cases v;as one who had given many 
times and whose donations had never been implicated in the development 
of jaundice in the recipients. The same safeguards applied to the plasma 
containing anti Rh. (D) but the risk remained. Clarke et al (I963) 
suggested the use of anti Rh. (D) gamma globulin by intramuscular
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injection in place of intravenous plasma as formerly. This plasma 
fraction is free from the risk of transmitting serum hepatitis.
Freda, Gorman and Pollack (1964) successfully used a preparation 
of anti Rh. (D) gamma globulin to prevent immunization using a series 
of Rh. negative male volunteers. This was similar to the studies by 
Clarke et al (I963)* Nine Rh. negative male volunteers were challenged 
monthly for five successive months with 2 ml. of Rh. positive red cells. 
Four of these volunteers were protected by intramuscular injections of 
5 ml. of anti Rh. (D) gamma globulin twenty-four hours before the anti­
genic challenge. Three months after the last injection the passively 
acquired Rh. antibodies were no longer demonstrable,in any of the four 
protected volunteers. There was no sign of active antibody production 
six months after the last injection. Four of the five controls, however 
were strongly sensitised.
Woodrow, Clarke, Donohoe, Finn, McConnell, Sheppard,Lehane, Russell 
Kulke, Durkin (I965) carried out a further series of studies and present 
ed evidence to support two important facts
(1) That foetal Rh. positive ABO compatible blood could be cleared from 
the circulation of Rh. negative women volunteers ( who were 
nulliparous and postmenopausal) by the injection of 5 ml. of anti 
Rh. (D) gamma globulin given intramuscularly.
(2) That transplacental haemorrhage occurred mainly just before or 
during delivery and that the size of the transplacental haemorrhage 
was related to the incidence of antibodies detected six months 
after delivery.
Woodrow and his colleagues now embarked on a clinical trial using
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anti Rh. (D) gamma globulin on Rh. negative primigravidae who were 
at most risk of developing antibodies, that is, women who were 
delivered of an Rh. positive ABO compatible foetus and who showed 
evidence of a transplacental haemorrhage using the Kleuhauer method 
of detecting foetal cells (Prevention of Rh. Haemolytic Disease - a 
combined study, I966).
Workers in this combined study examined a series of I56 Rh. 
negative primigravidae shown to be at risk by virtue of the foetal 
cells detected in their circulation after the delivery of an Rh. 
positive ABO compatible baby. Half of these patients were given 5 ral. 
of anti Rh. (D) gamma globulin not later than 36 hours after delivery, 
the other half serving as controls. Six months following the injection 
no immunization had developed in the treated patients but 19 of the 
controls had become immunized (24.3$)* Similar studies have been made 
by many workers - (Schweider and Preisler, I966; Robertson and Holmes, 
1969; Freda, Gorman, Pollack, Robertson, Jennings and Sullivan, 1967).
Initially 5 ml. of anti Rh. (D) gamma globulin was used but in the 
combined study (1966) it was suggested that 1 ml. might be enough.
Later as Clarke (I967) pointed out per millilitre was a meaningless way 
to judge the quantity of anti Rh. (D) given. Hughes-Jones (1967) by 
means of a labelling procedure was able to estimate the quantity of 
anti Rh. (D) present in gamma globulin in terms of ug. By testing 
material similar to that used in the Combined Study (I966) Clarke 
estimated that the amount of anti Rh. (D) used was in the order of 
1,000 ug./5ml. and suggested that a lower dose might be as effective. 
Dudok and De Wit, Borst-Eilers, V/eerot and Kloosterman (I968) showed 
that a dose of 25O ug. of anti Rh. (D) gamma globulin could protect 
against immunization. At the International Symposium on the Rh. 
problem in Milan (I969) Finn indicated that a 200 ug. dose was a safe 
suppressive amount of anti Rh. (D) gamma globulin.
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THE SUPPLY OF ANTI m. (P) GAMMA GLOBULIN
Once it had been shown that isoimmunisation of the Rh* 
negative pregnant woman could be prevented, the next most 
important problem in this field was a supply of raw material 
and hence gamma globulin*
There are several potential sources of anti Rh. (D) gamma 
globulin:-
(1) From individuals who have been immunised by transfusion.
This is fortunately a very rare occurrence in modern transfusion 
practice and the amount of raw plasma obtained from such individuals 
is very small.
(2) From women immunised by pregnancy.
This is the largest source of plasma containing Rh. antibodies. 
It is, however, one which will become less common as a programme of 
prevention of immunisation is carried out. Many of these women 
have become keen blood donors after pregnancy since they have them­
selves experienced the anxiety and sometimes tragedy of Haemolytic 
Disease in their children. The high titres which occur during 
pregnancy, however, are seldom sustained over a long period and in 
time the blood of such women has little antibody present. Attempts 
have been made to reduce high levels of antibody by plasmapheresis 
during pregnancy (Page 133) and this produces a source of high titre 
plasma. This has not yet become widespread in practice.
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While many women immunised by pregnancy give generously of 
their blood to produce gamma globulin this population is often 
not the most suitable to use. Apart from the obvious drawback 
of those who have a history of jaundice many of these mothers 
tend to have a history of anaemia or to be unavailable for blood 
donation because of domestic commitments. Many, too, are 
reluctant to give blood particularly if they have had a difficult 
confinement. If these women do donate blood it should be talcen 
by plasmapheresis rather than a straight donation as this method 
yields a larger amount of anti Rh. (D) containing plasma and also 
avoids depleting the donor of red blood cells.
(3) From postmenopausal or sterilized women
These are women who have usually been sensitized by a pregnancy 
and whose antibody has been boosted by an injection of Rh. positive 
red cells. These women are volunteers and to them apply the same
ethical and legal problems as apply to Rh. negative male volunteers. 
The injection of Rh. positive red cells carries a very small but 
definite risk of homologous serum jaundice. Before this injection
can be given these women must be medically examined and the 
implication of the injection of blood explained to them. Adequate 
legal arrangements must be made to compensate these volunteers and 
to cover the Medical Officer who gives the injection, if jaundice 
should occur. It is also essential to ensure that these women
should be given carefully matched blood should they require trans­
fusion in the future. There is liable to be particular difficulty 
about this if they should move to another country where blood trans­
fusion techniques are not highly developed. A further difficulty
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arises in those women who are sterilized and yet of childbearing 
age. If, by any chance, another pregnancy should occur these 
women will need to be offered termination of pregnancy.
(4) From Rh. negative male volunteers
These are Rh. negative males who have volunteered to be 
immunised by the injection of Rh. positive cells in order to 
stimulate the formation of antibodies. The same legal and 
ethical problems apply to these volunteers as to the female 
volunteers mentioned in the previous paragraph.
The risk of transmission of homologous serum jaundice as 
a result of the injection of red cells can now be reduced for 
these volunteers and for the women volunteers by testing the 
blood used for the presence of hepatitis associated antigen.
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QUANTITY OF ANTI RH. (P) GAMMA GLOBULIN REQUIRED
Initially plans were made to treat all primigravidae at greatest 
risk. In Scotland it was calculated from the frequency of the genes 
concerned that 11,500 mothers per year would be Rh. negative and bear 
Rh. positive ABO compatible children using the 1964 number of live births, 
This figure is made up of 2,700 primigravidae and 8,800 multigravidae. 
These figures are approximations.
If primigravidae alone were treated then on the assumption that 
1 ml. of 10g.$ immunoglobulin solution would be effective in clearing 
red cells and provide protection from immunization it was calculated 
that 83 litres of anti Rh. (D) containing plasma would be necessary and 
that this could be obtained from 340 donations per year.
If plasmapheresis were used and, assuming that each donor with 
acceptable antibody titres gave approximately 12 litres of plasma per 
year, by giving a double donation at two-weekly intervals, it was 
calculated that 7 such donors would suffice. This would be the minimum 
number possible and since it would be unlikely that these donors would 
always be available throughout the year, a more practical number would 
be l4 donors•
A similar calculation to that above shows that to prevent 
sensitization of all mothers, regardless of parity, who gave birth to 
ABO compatible Rh. positive infants in Scotland annually, some 280 
litres from 1,120 normal donors would be needed annually. Assuming 
that this amount of plasma could be obtained by plasmapheresis of 
suitable donors this could be obtained from a pool of 46 donors. These 
calculations do not take into account the extension of prevention to 
abortions and ABO incompatible pregnancies.
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Before the introduction of prophylactic anti Rh* (D) gamma 
globulin, blood from sensitized donors was collected in the 
normal way from approximately 1,000 donors per year in this 
region. This was used as anti serum for laboratory purposes 
only. When the need to increase the yield of antibody con­
taining plasma became evident the collection of such material 
was tackled more vigorously. Authority to sensitise or 
boost volunteers was not readily available and the best use had 
to be made of such sources as were available.
This was tackled initially by approaching women who had been 
pregnant recently or in the past and who were known personally to 
the author. With a few exceptions these ladies responded 
enthusiastically when the situation was explained to them. Where 
there had been an interval of some time, however, since the previous 
pregnancy the antibody titres were, in some instances, very low.
A further selection of donors was made by going through the old 
antenatal files of The Regional Transfusion Centre and inviting 
known sensitized women to donor sessions or offering them "home 
bleeds" i.e. a Medical Officer going to their homes and carrying 
out the venesection there. Eventually, when contact was made 
with many of these women, the lists were computerised and a regular 
call instituted to sensitised donors in all parts of the Western 
Region to attend local donor sessions. At this time plasma­
pheresis was not used. All maternity hospitals in the region 
were encouraged to notify The Regional Transfusion Centre of their 
sensitised cases and invited to obtain donations from their patients 
in the hospital concerned and to encourage them to become blood 
donors regularly.
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In January, I968 a group of sensitized women known to the 
author were invited to take part in a programme of plasmapheresis.
This group has been gradually expanded and there are now 80 women 
who give blood regularly by plasmapheresis.
As stated previously these women are a group who do not often 
have much free time by virtue of their domestic commitments and at 
present they attend only at two-monthly intervals.
PLASMAPHERESIS
This has been mentioned briefly on Page 13* It consists of 
withdrawing 500 ml. of blood by venesection into a plastic pack, 
which has a transfer pack attached, and thereafter keeping the vein 
open by infusing normal saline. The blood is centrifuged for 
15-20 minutes at 1,000 rev./min. in a mistral centrifuge and then 
the supernatant plasma is separated into the transfer pack* The 
packed cells are then returned to the donor and the process repeated.
It is by far the best way of obtaining a good yield of plasma - 
about 500-600 ml. from each double plasmapheresis. In addition, 
because there is little risk to the donor developing anaemia, since 
the cells are returned to the donor, donations can be given much more 
frequently than the straight donation of whole blood. Plasmapheresis 
carries the same risks as a straight donation of blood - infection, 
air embolus, vaso-vagal attacks, but with a careful technique these 
can be reduced to a minimal level. Haemoglobin levels are checked 
at every visit and if the process is carried out intensively, as it 
can be, plasma proteins should also be carefully observed. The double 
plasmapheresis takes about one and a quarter hours.
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Plasmapheresis is not without problems, other than the 
obvious medical ones. In this region those donors volunteering 
for plasmapheresis may need to spend an entire morning or after­
noon away from home because of the distance between their homes 
and The Regional Transfusion Centre. All of these donors are 
housewives, a few are working as well, and all have young 
families and domestic ties. In many cases they need to malte 
elaborate arrangements to have children looked after and those 
who are working need to arrange with their employers to be 
released from work to come to the Centre. In short, these donors 
may be put to considerable personal inconvenience in order to give 
blood.
The idea of monetary payment to volunteer blood donors has 
never been acceptable in Britain except where there is proven loss 
of earnings. These special donors are in the same category - 
that is, they give their blood on a voluntary basis. It is, 
therefore, of the utmost importance that these women are provided 
with comfortable transport facilities by The Transfusion Centre 
and that the plasmapheresis takes place in pleasant non-clinical 
surroundings. A special room for this purpose has just been 
provided at The Western Regional Transfusion Centre. In time, 
it is hoped to provide comparable accommodation and supervision 
for children so that they may accompany their mothers if necessary.
It is important, too, that a close personal contact is main­
tained between these donors and the transfusion staff who look 
after them. To achieve this purpose it is desirable that the same
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members of staff should be involved with these donors each 
time they donate blood. It can now be seen that the results 
of the use of anti Rh. (D) gamma globulin justifies the slight 
risk and considerable inconvenience to these donors, but at the 
same time, great tribute must be paid to these altruistic women 
who give so generously of their time and their blood to help 
others.
It is hoped that shortly permission will be given by The 
Scottish Home and Health Department to boost a selected panel 
of women, immunised by pregnancy, and who are now either post­
menopausal or have been sterilised. These women will be care­
fully selected, the risks of boosting explained to them, have a 
full medical check-up and be given an opportunity to discuss the 
procedure with their families and The Regional Transfusion Staff 
before the injection is given. These women would then undergo 
intensive plasmapheresis for some months and then be rested.
This would enable the number of plasmapheresis donors to be cut 
down, although it would be advisable to maintain an adequate 
number of non-boosted women for plasmapheresis to offset the drop 
out of any of the boosted donors for one reason or another. In 
any case, in terms of public relations, having persuaded a woman 
to take part in an ordinary programme of plasmapheresis it would 
be inadvisable to discontinue inviting her without a sound reason.
It would not be prudent to say that her blood was no longer of 
value since even low titres of anti Rh. (D) are used to dilute the 
concentrated preparation. Until the number of sensitized women 
is drastically reduced by prophylaxis it might, however, be enough 
to invite women with high titres to give blood 4-6 times after 
their pregnancy to supplement the pool of plasma from boosted female 
donors.
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As yet there is only one scheme in Scotland whereby Rh, 
negative male volunteers are immunised. Cook (I969) has 
successfully immunised I6 Rh, negative male volunteers. 
Preliminary studies of the yield of raw plasma obtained by 
plasmapheresis from these volunteers suggest that enough anti 
Rh. (D) gamma globulin to supply most of Scotland's needs can 
be produced from this source. On first impression this 
would seem to remove the need to boost pregnancy-immunised women 
but it must be remembered that several of these donors may opt 
out of the scheme for one reason or another and that the avail­
ability of a second source of supply is advisable. By making 
use of all accessible sources and increasing the supply of anti 
Rh. (D) gamma globulin it is hoped that in time prophylaxis may 
be available to all Rh. negative women at risk regardless of 
parity. It is doubtful whether Rhesus Haemolytic Disease can 
be completely eliminated as will be seen from the results of 
the use of anti Rh. (D) in the series presented later, but it 
must eventually come into the category of an uncommon disease.
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PRACTICAL TRIAL OF ANTI RH. (P) IMMUNOGLOBULIN
Since anti Rh. (D) immunoglobulin can, at the present time, 
be prepared only from human plasma containing anti Rh. (D) and 
its preparation is costly and time consuming, it is essential 
that its use should be adequately controlled. This means a close 
liaison between laboratory and clinicians and, while on paper 
this seems simple, in practice it can be very complicated. This 
is illustrated by the following description of initial use of 
anti Rh. (D) gamma globulin in Lanarkshire.
Towards the end of 196? a small supply of anti Rh. Cd) immuno­
globulin was made available for use in Lanarkshire. The object 
of the trial of this material was to try and determine the smallest 
effective dose of immunoglobulin. The material consisted of 36O
vials of 2 ml. of an immunoglobulin solution of varying microgramme 
content. There was an equal number of vials, each containing,
20, 30, 100 and 200 microgrammes of anti Rh. (D) gamma globulin.
The actual dose given was not known at the time of injection.
It was decided to limit the use of this material to the two 
main maternity hospitals - Bellshill Maternity Hospital and The 
William Smellie Memorial Hospital. It was further decided that
the material would be issued from The Regional Transfusion Centre 
and that all laboratory tests would be performed there. As each 
of these hospitals was situated 13 and 8 miles respectively from 
The Transfusion Centre a good deal of preliminary planning was 
necessary in order that a workable and efficient trial might be 
carried out.
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Initially, discussions on planning took place between the 
Senior Obstetricians concerned and The Transfusion Centre ataff 
and then The Senior Nursing Staff were asked to take part. It 
was anticipated that the supply of material would last for 
approximately two years and to avoid the difficulties of changes 
in Junior Medical Staff during this period it was felt that the 
permanent Senior Nursing Staff should be invited to co-ordinate 
the trial within their own hospitals with consultant supervision.
This they agreed to do. General Practitioners in the district 
were informed of the availability of the material within the 
Specialist Hospitals and invited to send their Rh. negative primigravid 
patients to hospital for delivery.
It was decided that the material should be given only to 
patients who fulfilled the following criteria;-
(a) Rhesus negative and primigravid
(b) Delivered of a Rhesus positive ABO compatible foetus
(c) Married
(d) Caucasian
Administrative arrangements within the hospital were made so 
that a small supply of gamma globulin, issued from The Transfusion 
Centre, would be kept in the labour-room of each hospital in charge 
of the labour-room supervisor or her deputy. This material was to 
be given to a patient on telephoned instructions to each supervisor 
from The Transfusion Centre following examination of maternal and 
cord blood. This injection had to be given within 36 hours of 
delivery.
To allow a proper selection of cases to be made, each Rhesus
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negative primigravida who was married and Caucasian, had her 
case sheet starred distinctly on admission to the labour-room 
and her name entered in a Special Register. Following delivery 
of the baby, specimens of maternal and cord blood (clotted and 
unclotted blood from each) were collected by the midwife in 
charge of the delivery and placed in a special labelled box in 
the labour-room.
Because of the distances involved between each hospital and 
The Transfusion Centre, and to avoid delay in examination of the 
blood specimens, transport from The Transfusion Centre called at 
each hospital twice daily - at 8.30 a.m. and 3*30 p.m. - to 
collect the specimens. This enabled all specimens to be examined 
and results 'phoned well within the time limits and prevented them 
having to be examined as emergencies.
At weekends one daily collection was made of specimens - once 
on Saturday and once on Sunday.
A group of senior laboratory technicians took part in the 
laboratory examinations. Apart from the weekends this was done 
within normal working hours. The examination of blood carried 
out included testing for the presence of anti D in the maternal 
blood, a check on the ABO and Rh. group, and a Kleihauer count.
The ABO and Rh. group of the foetal blood were determined and a 
haemoglobin estimation made on both baby and maternal blood. The 
technician who performed the blood tests was responsible for 
telephoning the nominated Senior Sister in each hospital to 
indicate whether a particular patient should be given the injection 
or not. The results of all tests, and whether the injection was 
to be given or not, were recorded on routine rhesus screening forms
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and also on a Special Register kept in The Transfusion Centre.
The actual injections were administered by a nominated Senior 
Sister in each hospital and this entered into the Register of 
patients entered in the trial and which was kept in each labour- 
room. The number of each vial and time of injection was also 
entered in each patient's case sheet.
A separate card, containing - name, address, age, blood group, 
and later obstetric details of delivery was also placed in each 
case sheet. To this was attached the number of each vial used. 
Prior to injection, each patient was given a leaflet explaining 
the purposes of the injection and explaining the importance of 
follow-up at six weeks and six months. Only one woman out of a 
total of 802 potential candidates refused to have the injection. 
Further specimens of maternal blood were taken on discharge and the 
patient asked to report back at six weeks and six months after 
delivery to have blood examined for the presence of antibodies.
The follow-up of patients proved the most difficult part of 
the trial. Even although the patients were given a date and time 
to report back to the hospital for follow-up many failed to do so. 
When a patient failed to come she was sent a letter reminding her 
about her check-up and offering a home visit if necessary to collect 
the blood. In many cases these letters were ignored. In defence 
of the patients one must say that the geographical position of the 
patient's home in relation to the hospital made travelling difficult 
and there was the added consideration that most liad also the care 
of a young baby.
Eventually after the last of the material was used and a six
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month interval had elapsed all the defaulters were again contacted 
and a series of home visits arranged. This brought the 77 
defaulters down to 7 none of whom could be traced.
The planning and carrying out of this trial required con­
siderable liaison and co-operation between the Transfusion Staff 
and Medical and Nursing colleagues. To all concerned, as one of 
the co-ordinators of this trial, I would express my gratitude for 
their help.
RESULTS
These are detailed in Table 1,
As might be expected the number of significant bleeds detected 
in the ABO compatible pregnancies with both Rhesus positive and 
negative babies was greater than in ABO incompatible pregnancies. 
The numbers involved, however, are very small.
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Three hundred and sixty Rhesus negative primigravid women 
received an injection of anti Rh. (D) gamma globulin out of a 
total of 802 considered. Three women have become sensitized and 
now show the presence of antibodies - This illustrates
that anti Rh. (D) gamma globulin does not provide absolute 
protection in the doses used but does reduce the incidence of 
sensitization to a very marked degree.
DETAILS OF FAILURES
TABLE 11
Case
Dose of 
anti Rh. (D) 
immunoglobulin
100 ug,
200 ug.
200 ug.
Foetal cell 
count
2 cells/
50 L.P. 
fields.
Not
significant
502 cells/ 
50 L.P. 
fields. 
Large bleed
No foetal 
cells
Time anti­
bodies 
developed
At delivery 
of second 
pregnancy
At delivery 
of second 
pregnancy
At 6th month 
“ second 
pregnancy
Type and 
titre of 
antibody
1/2 anti D 
by enzyme 
technique
1/16 anti D 
by I.A.G.T.
1/8 anti D 
by I.A.G.T,
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The present routine dose of 200 ug. would probably have 
prevented immunization in Case 1 and a larger dose, talcing 
cognisance of the unusually high foeto-maternal haemorrhage, 
would probably have prevented immunization in Case 2. There 
is no apparent explanation for Case 3 but it is possible that the 
patient may have had undetected foeto-maternal haemorrhages in the 
middle trimester of her second pregnancy and thus became sensitized.
Twenty of the total of 360 patients who received injections of 
this anti Rh. (D) gamma globulin have completed a successful second 
pregnancy by the end of I969 and have not shown the presence of 
antibodies. Nine of these twenty cases were again eligible for 
administration of anti Rh. (D) gamma globulin and were given 
injections of the standard preparation now in use. None of these 
patients showed immunization six months after delivery.
Further success in prevention of Rhesus sensitization can be 
seen in the general use of anti Rh. (D) gamma globulin in The 
Western Region of Scotland. The use of this, in 200 ug. doses, 
has not been quite so rigid as in the initial Lanarkshire series. 
While the use was confined to Rhesus negative women who delivered 
ABO compatible Rhesus positive babies, race and marital status were 
not defined. Many laboratories were involved in the blood exam­
inations, each with its own standard, and there was no central 
control.
The results of the use of anti Rh. (D) gamma globulin in the 
Western Region for the period 1st March, I968 - 31st October, 1970 
are shown overleaf.
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RESULTS OF GENERAL USE OF ANTI RH. (P) GAMMA GLOBULIN IN IÆST 
OF SCOTLAND REGION
(Survey from 1st March, 1968 - 31st October, 1970)
Total No. of injections - 1,671
No. without detectable antibody 6 months - 1,643 (9^.3^)
after delivery
No. with detectable antibody at 6 months - 22 (1.33^)
after delivery
No. with possible antibody present 6 months - 6 (0.36^)
after delivery
OBSERVATIONS ON 22 FAILURES
A foetal cell count was performed on only 4 of the failures.
No foetal cells were found in these 4 examinations. Five women, 
on close questioning after the appearance of anti Rh. (D) anti­
bodies in their serum, admitted to a previous pregnancy after which 
no anti Rh. (D) gamma globulin had been administered. Anti Rh. 
(D) gamma globulin does not, of course, have any protective action 
once a patient is sensitized. A further 5 women were unmarried.
CAUSES OF FAILURE OF PROTECTION
Protection against Rhesus sensitization by the use of Anti 
Rh. (D) immunoglobulin is not absolute. There are several 
possible reasons for failure. Sensitization is most common at 
delivery but occasionally a woman is sensitized by transplacental
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haemorrhage during pregnancy. In these cases the antibody 
titre may be too low to be detected and the woman appears to 
be unsensitized when the anti Rh. (D) immunoglobulin is given.
She is, in fact, sensitized and the anti Rh. (D) immunoglobulin 
cannot reverse the process.
Another reason for failure is that the woman may have a 
very large foeto-maternal haemorrhage which is not neutralised 
by the normal dose of anti Rh. (D) immunoglobulin. This is 
illustrated by Case 2 on Table 11.
A further reason for failure is poor laboratory control and, 
therefore, the lack of detection of antibody which is present.
This is one reason why the use of anti Rh. (D) immunoglobulin 
must be controlled by a nominated laboratory with high standards. 
This is particularly true when the material is used in maternity 
units outwith the specialist maternity hospitals as these non­
specialist hospitals often have no laboratory facilities within 
the particular maternity units. This is illustrated by the 
results in the use of National Health Service in The Western 
Region of Scotland when not all pre-injection laboratory procedures 
were carried out e.g. foetal cell counts. In widespread use, 
too, very rigid selection of patients may not be possible and 
apparently potential candidates may not admit to previous 
pregnancies. This, too, is shown in the results of the use of 
National Health anti Rh, (D) gamma globulin.
MATERNAL RISKS OF ANTI RH. (D) D#UNOGLOBULIN
The risk of transmission of serum hepatitis was eliminated
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with the preparation of the immunoglobulin form of anti Rh, (D) 
by fractionation procedures (Hollison, 1967b). Local discomfort, 
sometimes associated with fever of no more than 24 hours duration, 
has occasionally been reported (Clarke, I968).
Although systemic reactions are rare, sensitization to gamma 
globulin has been reported (Clarke, I968) and this possibility 
should be kept in mind. If antibodies to gamma globulin are found, 
anaphylactic phenomenon may occur at some future time when gamma 
globulin is again given. This is obviously a rare possibility in 
view of the vast amount of gamma globulin which has been given and 
the rarity of reports of sensitization. For practical purposes 
this probably need only concern patients with hypogammaglobulinaemia 
(Henney and Ellis, I968). If this problem proves to be significant 
it may be solved by the use of plasmin treated immune serum globulin 
(Scouris, 1967).
It has long been recognised that intravenous administration of 
gamma globulin is dangerous (Barundun, Kistler, Jeunet and Isliker, 
1962) therefore the immunoglobulin must be given intramuscularly.
It is not advisable to give anti Rh. (D) immunoglobulin to Rhesus 
positive women although Clarke (I968) reported two cases where the 
injection was given to two patients who were later found to be Rhesus 
positive and no reaction occurred. In discussion at the International 
Symposium in the management of the Rhesus problem in Milan, I969 Chown 
reported that two Rhesus positive babies had been given the injection 
of immunoglobulin intended for their mothers. Apart from developing 
a weakly positive Coomb's test these infants showed no reaction.
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EXTENSION OF THE USE OF ANTI RH. (P) GAMMA GLOBULIN
The trial of the initial material made available for use 
in the Lanarkshire Specialist Maternity Hospitals ended on 3th 
January, 1970.
From 1st March, 1968 anti Rh. (D) gamma globulin was made 
available for general use in Specialist Maternity Hospitals to 
Rhesus negative unsensitized patients who had no living children 
and who were delivered of a Rhesus positive ABO compatible child.
No differentiation was made on the marital status or race of the 
patients.
On 13th December, 1969 the use of anti Rh. (D) gamma globulin 
was extended to include Rhesus negative women without antibodies 
delivering a second child who was Rhesus positive and ABO compatible* 
At the same time the material was made available for use in the 
General Practitioner Maternity Units, provided the necessary maternal 
and cord blood specimens were examined in a designated laboratory.
The effect of this latter extension was to relieve the pressure on 
Specialist Maternity Hospital beds. Hitherto,all appropriate 
Rhesus negative patients liad to be confined in Specialist Maternity 
Hospitals and the great majority had normal pregnancies and deliveries 
which could have taken place satisfactorily outwith these hospitals.
From 1st October, 1970 the use of anti Rh. (D) immunoglobulin 
has been extended to cover all non-immunised women in first or 
second pregnancies delivering a Rhesus positive baby regardless of 
the ABO group. In addition the material is now available for Rhesus 
negative women without a live child who have an abortion.
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In all of these cases the same rigid laboratory control has 
been carried out with the exception that the Rhesus group of the 
foetus is not known in early abortions. The Regional Transfusion 
Centre has been nominated as the laboratory in Lanarkshire where 
all the specimens of blood are examined. This has meant an 
extension of the transport arrangements as for the initial use of 
anti Rh. (D) but as the time limit for injection has been extended 
to 60 hours in place of the original 36 hours the timing of trans­
port is not quite so critical.
FUTURE USE OF ANTI RH. (D) IMMUNOGLOBULIN
The introduction of anti Rh. (D) is one of the major steps in 
prophylactic medicine. Although Haemolytic Disease is not a 
major disease in terms of numbers, in terms of human involvement it 
is important.
The use of this material is being extended as the raw material 
becomes available and it seems only logical that it should be 
extended to cover ALL women at risk regardless of parity. The 
initial use, restricted to Rhesus negative primigravidae at special 
risk, ensured her of at least two children unaffected by Haemolytic 
Disease. When the use was extended to second pregnancies such a 
patient was ensured of three children unaffected by Haemolytic 
Disease. Now the use is extended to Rhesus negative primigravidae 
and secundigravidae who are at less risk by virtue of delivering an 
ABO incompatible child. In addition patients without a live child 
and having an abortion are now eligible to be treated with anti Rh. 
(D) immunoglobulin.
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There could be no argument against the use of anti Rh. (D) 
in the first two groups of patients ™ the Rhesus negative 
primigravidae and secundigravidae delivering a Rhesus positive 
baby. The question of abortion, however, raised problems.
The patient having a spontaneous abortion and having no living 
children should again be treated without argument.
The introduction of the Abortion Act in 196?, however, has 
caused an increase in the number of abortions per year in all 
groups of patients and dissention has arisen over the use of ànti 
Rh. (D) gamma globulin in these cases* It is generally agreed 
that the later the abortion the more risk there is of foeto- 
maternal bleeding and hence risk of sensitization but many 
therapeutic abortions are carried out before l6 weeks. Opinion 
is divided as to how important these early abortions are in 
production of Rhesus isoimmunization. Murray, Barron and McNay 
(1970) suggest that there is insufficient evidence to justify 
blanket administration of anti Rh. (D) immunoglobulin while Freda, 
Gorman, Galen and Tracy (1970); Edwards (1970); Goldman and 
Eckerling (1970); Walsh and Lewis (1970) indicate that anti Rh.
(D) immunoglobulin should be given to all patients undergoing 
termination of pregnancy at any stage and by whatever method.
In a series of 917 sensitized cases there were 4 women who 
became sensitized following an abortion. The time of the abortions 
varied from 10-26 weeks but it is interesting to note that all 4 
have had a history of severe Haemolytic. Disease. Two of them had 
intra-uterine transfusions to procure a live child and indeed one 
patient has only 2 live children out of 5 pregnancies.
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Although the number of patients sensitized by abortion in 
this series is very small the effect has been so devastating in
these cases that it warrants a "prevention if at all possible"
approach to the problem. The incidence of abortion will increase 
as a result of the Abortion Act of 196? and it is often not easy
to obtain a follow-up of these patients but it would seem that they
should be given the benefit of anti Rh. (D) immunoglobulin. This
is particularly true of the young unmarried girl undergoing
termination. If sources of anti Rh. (D) immunoglobulin are 
properly mobilised the absorption of all women at risk because of 
an abortion into the recognised categories of patients to be treated 
is surely justified.
The problem of Rhesus Haemolytic Disease of the Newborn has
existed for many years but it seems that now the problem will be on
a minimal scale. Much work by many people has gone into the 
investigation, management and now prevention of this disease. It 
is perhaps a classic example of the interdependence of clinicians 
and laboratory worker in finding a solution to one of the mysteries 
of medicine. The result has certainly been successful in removing 
the fear of the effects of Haemolytic Disease on the children of many 
thousands of women.
175.
R E F E R E N C E S
ASCAEI, W.Q., LEVINE, P., and POLLACK, W. (I969). Incidence of 
maternal Rh. immunization by ABO compatible and 
incompatible pregnancies. Brit. Med. J. • 599
BARUNDUN, S., KISTLER, P., JEUNET, F. and ISLIKER, H. (1962).
Intravenous administration of human globulin.
Vox. Sang. 7^  : 137
BORST-EILERS, E. (I96O). The foetal origin of red cells staining 
with Kleihauer*s technique, as established by the 
application of the "mixed agglutination" reaction on 
the cells. Vox. Sang. 6 : 431
BROMBERG, Y.M. , SALZBERGER, M. and ABRAHAKOV, A. (1937). Allcali 
resistant type of haemolgobin in women with molar 
pregnancy. Blood 12 : 1,122
CARTER, BETTINA B. (194?). Preliminary report on a substance which 
inhibits anti Rh. serum. Am. J. Clin. Path. 17 : 646
CARTER, BETTINA B. (1949). Rh. hapten : Its preparation, assay
and nature. J. Immunol. 6l : 79
CARTER, BETTINA B., WILLIAMSON, A.C., LOUGHRET,- J. , and INGRAM, C.
(1936). Evaluation of Rh. hapten. Am. J. Obst. & Gynec.
72 : 633
CARTER, BETTINA B., and LEWIS, Â.F. (1938). The effects of orally
administered Rh. hapten. Am. J. Obst. & Gynec. 76 : 1,283
CARTER, BETTINA B. (1939). A survey of the Rh. hapten. Tex. Rep. Biol.
Med. 22, : Ï73
CHOWN, B. (1934). Anaemia from bleeding of the fetus into the mother's 
circulation. Lancet 1 : 1,213
CHOWN, B. (1968). On Rh. immunization and its prevention. Observation
and thoughts. Editorial. Vox. Sang. 13 : 249
CHOVJN, B. (1970). Personal Communication
CLARKE, C.A., DONOHOE, W.T.A., McCONNELL, R.B., WOODROW, B.C.,
FINN, R., KREVENS, J.R., KÜLKE, W., LEHANE, D. and 
SHEPPARD, P.M. (1963). Further experimental studies 
on the prevention of Rh. haemolytic disease. Brit. M. J.
1 : 979
176,
CIARKE, C.A. (1967). Prevention of Rh. Haemolytic disease. Brit. M.J. 
A  : 7
CIARKE, C.A. (1968). Prophylaxis of Rhesus Iso-immunization. Brit. 
Med. Bull. Vol. 3#
CLARKE, C.A.,' ELSON, G.J., BRADLEY, J., DONOHOE, W.T.A., LEHANE, D.
and HUGHES-JONES, N.G. (1970). Intensive plasmapheresis 
as a therapeutic measure in Rhesus isoimmunised women. 
Lancet 1 ; 793
COHEN, FLOSSIE., ZUELZER, W.W. (1964). Identification of blood group
antigens by immunofluorescence and its application to the 
detection of transplacental passage of erythrocytes in 
mother and child. Vox. Sang. 9 * 75
COHEN, FLOSSIE., ZUELZER, W.W., GUSTAFSON, D.C. and EVANS, M.M. (1964) 
Mechanisms of isoimmunization I. The transplacental 
passage of fetal erythrocytes in homospecific pregnancies. 
Blood. 2 2  : 621
COHEN, FLOSSIE, and ZUELZER, W.W. (I967). Mechanisms of immunization II 
Transplacental passage and postnatal survival of fetal 
erythrocytes in heterospecific pregnancies. Blood 30 :
796
COOK, I.A. (1969). Personal Communication
DeCOSTA, E.J., GERBIE, A.B., and POTTER, EDITH L. (1954). Cortisone 
and erythroblastosis : Evaluation of management of
pregnancy in Rh. immunized woman. Obst. & Gynec. 3 • 1
DUDOK DE WIT, C., BORST-EILERS, E. , WEERDT, CH.M. V.D. ,* and
KIOOSTERMAN, G.J. (I968). Prevention of Rhesus immunisât
A controlled clinical trial with a comparatively low dose
of Anti D Immunoglobulin. Brit. M. J. 4 : 477
EDWARDS, R.F. (1970). The place of Anti D Gamma Globulin in abortion.
Australian & New Zealand J. Obst. & Gynaec. 10 : 96
FINN, R., CLARKE, C.A., DONOHOE, W.T.A., McCONNELL, R.B., SHEPPARD, 
P.M., LEHANE, D. and KÜLKE, W. (I96I). Experimental
studies on the prevention of Rh. haemolytic disease.
Brit. M. J. 1 ; 1,486
177,
FINN, R. , HARPER, D.T., STALLINGS, S.A., and ICREVANS, J.R. (I963). 
Transplacental haemorrliage. Transfusion 3 : ll4
FINN, R.(1970). International Symposium on the Management of the Rh. 
problem. Milan. Annali Obstetricia Ginecologia.
Special number. Page 26
FRASER, I.D., and RAPER, A.B. (1962). Observations of compatible 
and incompatible foetal red cells in the maternal 
circulation. Brit. M. J. ^  : 303
FREDA, V.J., G0R4AN, J.G., and POLLACK, W. (1964). Successful
prevention of experimental Rh. sensitization in man with 
an Anti Rh. Gamma globulin antibody preparation : A
preliminary report. Transfusion : 26
FREDA, V.J., GORÎ^ IAN, J.G., POLLACK, W. , ROBERTSON, J.G., JENNINGS,
E.R., and SULLIVAN, J.F. (I967). Prevention of Rh. iso
immunisation. Progress report of the clinical trial in 
mothers. J. Am. Med.Assoc. 199 : 300
FREDA, V.J., GORMAN, J.G., GALEN, R.S. and TREACY, N. (1970).
Threat of Rh. immunisation from abortion. Lancet _2. • 3.4
GODEL, J.C., BUCHANAN, D.I., JAROSm, JEAN M. , and McHUCH, MAUREEN 
(1968). Significance of Rh. sensitization during
pregnancy. Its relationship to a preventive programme.
Brit. M. J. 4 : 479
GOLDMAN, J.A., and ECKERLING, B. (1970). Transplacental haemorrhage 
during spontaneous and therapeutic artificial abortion. 
Obst. & Gynec. 35 • 903
HENNEY, C.S., and ELLIS, E.F. (I968). Antibody production to
aggregated human gamma-G-Globulin in acquired hypogamma­
globulinaemia. New Eng. J. Med. 278 : l,l44
HUGHES-JONES, N.C. (I967)* The estimation of the concentration and 
equilibrium constant of anti-D. Immunology 12 : 5&5
HUNTER, O.B. (1954). Cortisone therapy in Rh. incompatibilities.
J. Am. Med. Assoc. 154 : 905
  f
JONES, A.R., and SILVER, SHEILA (1958). The detection of minor
erythrocyte populations by mixed agglutinates. Blood
13 : 763
1 7 8 .
KATZ, J. (1969). Transplacental Passage of Fetal Red Cells in 
Abortion. Increased Incidence after Curettage and 
Effect of Oxytocic Drugs. Brit. M. J. 2L • 84
KLEIHAUER, E., BRAUN, and BETKE, K. (1957). Demonstration 
von fetalen hemoglobin in den erythrocyten eines 
blustausstrichs. Klin. Wschr. 35 * 637
KREIGER, VERA I. (I966). Serological evidence in relation to the 
time of initial immunization of the rhesus negative 
mother. J. Obst. 8c Gynaec. Brit. Comm. 73 : 99
LEVINE, P., BURNH/m, L., KATZIN, E.H., and VOGEL, P. (1941). The
role of isoimmunisation in the pathogenesis of 
erythroblastosis fetalis. Am. J. Obst. & Gynec. 4^ : 925
LEVINE, P., KATZIN, E.M., and BURNHAM, L. (1941). Isoimmunisation 
in pregnancy. J. Am* Med. Assoc. II6 : 126
LEVINE, P. (1943) Serological factors as possible causes in spontaneous
abortions. J. Hered. 34 : 71
LEVINE, P. (1958). The influence of the ABO system on Rh. haemolytic 
disease. Hum. Biol. 3^ î 13
MAURER, H.M., WOLFF, J.A., FINSTER, M,, POPPERS, P.J., PANTUCK, E.,
KUNTZMAN, R., and CONNEY, A.H. (I968). Reduction in
concentration of total serum bilirubin in offspring of 
women treated with Phenobarbitone during pregnancy.
Lancet 2. • 122
MOLLÏSON, P.L. (1967a). Blood Transfusion in Clinical Medicine.
4th ed. P. 305>
HOLLISON, P.L. (1967b). Blood Transfusion in Clinical Medicine.
4th ed. P. 113
MURRAY, SHELAGH (I967), Rh. antibody type in haemolytic disease of 
the Newborn. Vox. Sang. ^2 : 8l
MURRAY, SHELAGH, KNOX, E.G., and WALKER, W. (I965). Rhesus haemolytic 
disease of the newborn and the ABO groups. Vox. Sang.
10 : 6
179.
MURRAY, SHELAGH., BARRON, S.L., McNAY, R.A. (1970). Transplacental 
Haemorrhage after abortion. Lancet 1 ; 63I
NEVANLÏNNA, H.R., and VAINIO, T. (1956). The influence of mother-
child ABO incompatibility on Rh. immunisation. Vox. Sang.
. JL^  : 26
PARMLEY, T.H., MONTAGUE, A.C.W., MILLER, EUGENIA (1970).
Transplacental hemorrhage in patients subjected to 
therapeutic abortion. Am. J. Obst. & Gynec. Vol. IO6 
P. 540
PEARSE, W.H., and HOBEL, G. (1964). Inhibition of Rh. antibodies.
Am. J. Obst. & Gynec. 89 : 46
POLIGCK, A. (1968). Transplacental haemorrhage after external 
cephalic version. Lancet 1 : 612
POV/ELL, L.C. (1968) Intensive plasmapheresis in the pregnant Rh.
sensitized woman. Am. J. Obst. & Gynec- 101 : 153
Prevention of Rh, haemolytic disease : Results of the combined trial.
A combined study from centres in England and Baltimore. Brit. M. J.
1966. 2 . : 907
RACE, R.R., and SANGER, RUTH (1950). Blood Groups in Man. 1st Ed.
P. 290
RAWSON, A.J., and ABELSON, N.M. (I96O). Studies of blood group 
antibodies IV. Physiological differences between 
isoanti-AB and isoanti-A or isoanti-B. J. Immunol.
85 : 640
ROBERTSON, J.G., and HOLMES, CONSTANCE M. (I969). A clinical trial
of Anti-Rhg (D) immunoglobulin in the prevention of Rhg (D 
immunization. J. Obst. & Gynaec. Brit. Comm. 76 : 252
RUCKNAGEL, D.L., and CHERNOFE, A.I. (1955). Immunologic studies of 
haemoglobins III. Foetal haemoglobin changes in the 
circulationof pregnant women. Blood 10^  : 1,092
SCHNEIDER, J,, and PREISLER, 0. (I966). Prevention of Rh. sensitizati 
from fetomaternal microtransfusions. Obst. & Gynec.
28 : 615
l8o.
SCOTJRIS, J.T, (1967). Preparation of Plasmin Treated Immune Serum 
Globulin for Intravenous use. Vox. Sang. 13 : 71
STERN, K., GOODMAN, H.S. and BERGER, M. (196I). Experimental
isoimmunisâtion to heraoantigens in man. J. Immunol.
87 : 189
STERN, K., DAVIDSON, I., and MASAITIS, L. (1936). Experimental
studies on Rh. immunization. Am. J. Med.Sci. 26 ; 833
TAYLOR, W.C., and KULLMAN, G. (I96I). The detection of foetal
erythrocytes in blood smears. J. Obst. & Gynaec. Brit. 
Comm.. • 261
TROLLE, D.(1968). Decrease of total serum-bilirubin concentration in
newborn infants after phenobarbitone treatment. Lancet
A  : 705
VOIGT, J.G., and BRITT, R.P. (1969). Feto-maternal haemorrhage in
therapeutic abortion. Brit. M. J. _4 : 393
VOS, G.H, (1966). Antenatal immunization by the Rh. factor and ABO 
blood group incompatibility between mother and child. 
Vox. Sang. 12 : 460
VOS, G.H. (1967)# The Effect of External Version on Antenatal
Immunization by the Rh, Factor. Vox, Sang. 12 : 390
WALSH, J.J., and LEWIS, B.V. (1970). Transplacental haemorrhage due
to termination of pregnancy. J. Obst. & Gynaec. Brit.
Comm. 77 : 133
WIENER, A.S. (1948). Diagnosis and treatment of anaemia of the newborn 
caused by recent placental hemorrhage. Am. J. Obst. & 
Gynec • 3^ * 717
WIENER, A.S. (1934). Cortisone therapy in Rh. incompatibility.
J. Am* Med. Assoc. 133 : 63
WOODROW, J.C., CLARKE, C.A., DONOHOE, W.T.A., FINN, R., McCONNELL, 
R.B., SHEPPARD, P.M., LEHANE, D., RUSSELL, SHONAH, 
KULKE, W., and DURKIN, CATHERINE, M. (1963). Prevention 
of Rh. haemolytic disease ; A third report. Lancet
1 : 279
I8l.
WOODROW, J.G., and FINN, R. (I966). Transplacental Haemorrhage. 
Brit. J. Haematology 12 : 297
ZIPURSKY, A., HULL, A., WHITE, F.D., ISRAELS, L.G. (1959).
Foetal erythrocytes in the maternal circulation.
Lancet 2. • 451
ZIPURSKY, A., NEELANDS, P., POLLOCK, JANET, CHOWN, B., ISRAELS, L.G.
(1961). Foetal Haemoglobin, synthesis in some 
haemoglobinopathies. Lancet 12 : 154
ZIPURSKY, A., NEELANDS, P., POLLOCK, JANET, CHOW, B. , ISRAELS, L.G.
(1962). The distribution of fetal hemoglobin in the 
blood of normal children and adults. Paediatrics
30 : 262
ZIPURSKY, A., POLLOCK, JANET, NEELANDS, P., CHOW, B., and ISRAELS,
L.G. (1963). The transplacental passage of foetal red
blood cells and the pathogenesis of Rh. immunisation 
during pregnancy. Lancet 2 : 489
TABLE 11
1---------- — — — — — — ---—— '— ----- :—— —— — —— — — - ---—"— - -- -
Ca.so_
Mo.
_lst_I.U.T,
weeks
Mo. of 
I.U.T's
Delivery 
1 weeks
Adult
Colls I.A*
Cord Blood 
G.T. Bb.
gm./
Bil. Outcome Treat
1 28^ 2 33 M.D, liaenolysed S.B. -
2 32 2 34 M.D. Haeniolysed S.B. -
3 28 2 31 8c$j •!' 4.9 4.4 H.M.D. 2 exchanges
k 3li 1 . 33 M.D. Haemolysed S.B. -
5 32 1 33 20;j 4- 10.2 6,2 A2:W 3 exchonjes
6 31 2 3^1^- 3Uo -Î- l^A 7.1 A & W 2 exchanyec
7 28 3 37 6(% + 7 6,4 A & W 1 exchange
8 32 1 37 3(%4 4 7 6.4 A & W 1 exchange
9 29 3 37 70# 4 10.4 4.8 A W 2 exchanges
10 32 2 34 M.D. Haemolysed S.B. -
11 30 2 33 4- 10.6 7 .3 M.M.D. 2 Gxchenyes
12 3G 1 34 3G^ u 4 9 .6 6 .6 A & W 3 excbcages
1.3 31 1 36 7Q): + 8.4 8 .1 A & W 2 exchanges
3.4 26 3 33 IOC# 12.4 3 .1 A ^ ^ 3 top-ups
' '' 27 ■ 11 ■
Haorolyrr'd
1
16 26 3 33 10L%j 13 .6 3/\
17 30 2 10 .8 6J4
j
18 30 2 33 8u,i 4- 3.0 i\ 0 1* i.7 0
].9 29 2 33 M.D. Hacmolyccd S.B.
26 1 30 M.D. Haemolysed S.B.
21 1 28 1 33-2 20/. + 3.2 3 .2 i'j * «■ J.'i'î "
22 28 1 29 30/.: 4- 1 .8 - N.H.D. “
287 36-1 Tf.C. Ilaenolysod H.M.D.
24 31 3 33 ihaDa Haemolysed S.B. -
29 32I 1 35 N«D« Haemolysed S.B. -
26 29 1 31 2G# 3 4.6 H.H.D. partial exi
I.U.T.
U.îi. D. 
A & W
N o D.
Intra-uterine Transfusion
Stillbirth
Neo-nato.l Death
Alive and well
Not done
S U M M A R Y
The object of this Thesis is to present and discuss various 
aspects of Management and Prevention of Rhesus isoimmunization within 
a County Obstetric Service which caters for a population of 600,000. 
The work presented was carried out over the years 195S - 1968, partly 
within the County Obstetric Service and partly with the Regional 
Transfusion Centre.
The first chapter traces the history of Rhesus isoimmunization 
starting in 1939 with the beginning of the elucidation of the Rhesus 
factor and its connection with the syndrome of erythroblastosis 
foetalis. The advances in the knowledge of this factor and its 
effect are followed throughout the subsequent years. The management 
of pregnancy and treatment of the newborn are also followed from earl 
induction of labour based on antibody titre and original exchange 
transfusion of the baby to the present day assessment by liquor amnii 
bilirubin content and treatment of the severely affected baby by 
intra-uterine transfusion. The early attempts at amelioration of the 
effects of isoimmunization during pregnancy are described and follows 
to the present use of anti Rh. (D) gamma globulin to prevent the 
sensitization of the Rhesus negative mother to the Rhesus factor.
The second chapter describes how the pattern of management has 
evolved over the past eleven years. First came the establishment oi 
special clinics for sensitized patients, followed by the introduction 
of the diagnostic aid of amniocentesis. This chapter includes a 
broad picture of the material studied, including tables detailing tyj 
of antibody found, frequency of antibody, ABO relationship of parente 
and baby and parity. The overall results are presented as represent
the three periods:- (1) pre Rhesus clinic (2) Rhesus clinic and 
(3) Rhesus clinic plus amniocentesis and show how the perinatal 
mortality has improved, reflecting the improvement in antenatal 
care.
The third chapter contains a detailed review of the use of 
liquor amnii bilirubin content in the prediction of the severity of 
erythroblastosis of the foetus. The technique and risks of amnio­
centesis are fully described* One hundred and seventy three cases 
are presented in detail and correlation made between the liquor amnii 
prediction and the condition of the baby at birth as judged by the 
cord haemoglobin and bilirubin. These correlations were not always 
found to be satisfactory and a better correlation was found between 
liquor amnii prediction and a suggested Cord Blood Factor obtained 
from the ratio cord haemoglobin in gms./ divided by the cord bilirubin 
in mgm.^ o. (These results are presented in tabular and diagrammatic 
form).
The fourth chapter gives a detailed review of the use of intra­
uterine transfusion of the foetus from the original paper describing 
this procedure to the present time. The selection of cases, risks 
to mother and foetus and the present status of intra-uterine trans­
fusion are considered.
Twenty-six pregnancies so treated are fully discussed in detail 
and the survival rate is shown to be similar to the various published 
series. The various operative techniques are fully discussed and a 
short joint publication on technique is included. The cause of peri­
natal mortality is given when possible for the babies which did not 
survive.
The final chapter deals with the prevention of Rhesus 
isoimmunization. It describes the early attempts to ameliorate 
the effects of immunization on the foetus and later the recent work 
on prevention of isoimmunization by the use of anti Rh. (D) gamma 
globulin. The background and experimental work in this field is
described. The sources of raw material necessary to prepare anti
Rh. (D) gamma globulin are considered and experience in the use of 
plasmapheresis to obtain this material is described.
A series of cases treated with anti Rh# (D) gamma globulin before 
the general introduction of anti Rh. (D) gamma globulin is presented 
and the practical difficulties of administration discussed. The 
results of its use in a wider series is also presented.
The relevant literature has been reviewed in all chapters and 
references are shown at the end of each chapter.
